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Abstract
This study examined factorial invariance of three self-report measures of psychiatric
symptoms—the World Health Organization Adult ADHD Self-Report Scale (ASRS; Kessler et
al., 2005), the Center for Epidemiologic Studies Depression Scale-Revised (CESD-R; Eaton,
Smith, Ybarra, Muntaner, & Tien, 2004), and the Depression Anxiety Stress Scales (DASS;
Lovibond & Lovibond, 1995)—using a convenience sample of 434 adults surveyed though
Amazon Mechanical Turk. Participants were sorted into two groups based on their score on the
Autism-Spectrum Quotient (AQ; Baron-Cohen, Wheelwright, Skinner, Martin, & Clubley,
2001). Of 423 participants included in the final sample, 203 were included in the low ASD traits
group and 220 were included in the high ASD traits group. Results indicated that the CESD-R
did not demonstrate configural invariance, such that the same latent constructs did not emerge
across both the low ASD traits and high ASD traits groups. Further, the CESD-R did not possess
the same factor model specifications as previously established in general and clinical adult
populations. The DASS-21 demonstrated evidence of scalar invariance, indicating cross-group
equality in factor loadings and factor intercepts. The ASRS demonstrated evidence of metric
invariance in the current sample, indicating that the established latent factors were represented in
the data but that the levels and relations among those factors differed across groups. Findings
from this study demonstrate that the DASS-21 and the CESD-R are not fully invariant across
those with and without a high level of ASD traits, such that scores on these measures may not be
valid when assessing symptoms of depression and anxiety in the ASD population.
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Factor Invariance of Anxiety and Depression Measures in Autism
Autism spectrum disorder (ASD) is a neurodevelopmental disorder marked by deficits in
social communication and social interaction, as well as the presence of repeated, restricted
patterns of behavior, interests, or activities (American Psychiatric Association, 2013).
Impairment in social communication and interaction may include deficits in social-emotional
reciprocity, nonverbal communicative behaviors used for social interaction, or understanding and
establishing social relationships. As its name implies, ASD is a heterogeneous construct that is
thought to exist on a continuum, such that the phenotype can be conceptualized as a set of
continuous traits that exist in the general population (Sucksmith, Roth, & Hoekstra, 2011), with
people with a diagnosis of ASD scoring at the extreme end of this distribution (Baron-Cohen,
2010). Previous research has indicated that the component traits of the autism spectrum are
distributed across the population and potentially have distinct etiologies (Robinson et al., 2016;
Bralten et al., 2017).
In 2014, the overall prevalence of ASD was 16.8 per 1,000 (one in 59) children aged 8
years, with males four times more likely than females to be identified with ASD (Autism and
Developmental Disabilities Monitoring [ADDM] Network, 2018). ASD prevalence estimates
increased from 6.7 to 16.8 per 1,000 children aged 8 years, an increase of approximately 150
percent, from 2000 to 2014 (ADDM Network, 2018). It remains unclear whether this increase is
reflective of a true increase in prevalence or increased awareness of ASD and changes in
diagnostic practices (Maenner et al., 2014). Regardless of which factors are driving this increase
in prevalence, it remains the case that increasing numbers of children will be diagnosed with
ASD, and that more individuals with ASD are entering the educational, medical, and community
systems than ever before. This increase in the number of individuals entering these systems
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warrants research into effective and evidence-based practices in each of these settings.
Heretofore, common measures of adult outcome, including educational attainment, employment
status, physical and mental health status, and quality of life have been poor for the population of
individuals with ASD (Billstedt, Gillberg, & Gillberg, 2011; Farley, Cottle, Bilder, Viskochil,
Coon, & McMahon, 2018; Howlin & Moss, 2012; Howlin, 2000). As a result, individuals with
ASD may be underestimated, despite their skills and capabilities (Courchesne, Meilleur, PoulinLord, Dawson, & Soulieres, 2015).
The Stakeholder Perspective
In 2015, federal and private foundation funding for autism research in the United States
exceeded $342 million (Office of Autism Research Coordination, National Institute of Mental
Health, on behalf of the Interagency Autism Coordinating Committee, 2017). Recent research
has indicated that this funding often does not match the needs and priorities of the autism
community itself (Pellicano, Dinsmore, & Charman, 2014). Gotham et al. (2015) used online
survey data from a large sample of adults with ASD and their legal guardians to investigate
outcomes across a variety of contexts, as well as stakeholders’ priorities for future research.
Areas of poorest adult outcome were associated with co-occurring physical and mental health
conditions, vocational engagement, and low levels of adaptive behavior. In fitting with these
outcomes, stakeholders indicated a need for more ASD research focused on life skills,
treatments, co-occurring mental and emotional health conditions, and vocational and educational
opportunities. Similarly, stakeholders and members of the ASD community based in the United
Kingdom identified research focused on effective public services and evidence-based
interventions as a priority (Pellicano, Dinsmore, & Charman, 2014).
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Co-occurring mental health conditions pose particular concern, given that traditional
diagnostic measures have largely not been tested for validity and reliability in ASD populations
(Leyfer et al., 2006). In keeping with the aforementioned ASD stakeholder priorities for
research, the present study seeks to examine anxiety and depression in ASD, with particular
focus on whether these constructs are measured reliably and validly in this population using
common self-report instruments originally normed in the general population. Anxiety and
depression may be difficult to assess in individuals with ASD, given that their presentation may
be atypical or complicated by the social and communicative impairments inherent to autism
(Stewart, Barnard, Pearson, Hasan, & O’Brien, 2006). The phenotypic overlap between these
conditions and ASD, as well as the tendency for ASD symptomatology to mask anxiety and
depression symptoms (Magnuson & Constantino, 2011), makes the psychometric examination of
existing self-report measures in individuals with ASD an empirical question of importance.
Comorbidity in ASD
ASD commonly co-occurs with other developmental, neurological, psychiatric, and
genetic diagnoses (Gurney, McPheeters, & Davis, 2006; Matson & Nebel-Schwalm, 2007). In a
population-based cohort of 2,568 eight-year-old children meeting surveillance case criteria for
ASD, the co-occurrence of one or more non-ASD developmental diagnoses was 83 percent, and
the co-occurrence of one or more psychiatric diagnoses was 10 percent (Levy et al., 2010).
Children with ASD have been found to have significantly higher levels of psychopathology as
compared to children with intellectual disability (Brereton, Tonge, & Einfeld, 2006). Still, age
and intellectual functioning may be important factors to consider with regard to comorbidity in
the population of adults with ASD. In a study of adults with ASD and intellectual disability,
Totsika, Felce, Kerr, and Hastings (2010) found that psychiatric disorders were less frequent in
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older adults with ASD and those with an intellectual disability compared to younger adults with
co-occurring ASD and intellectual disability. Conversely, Roy, Prox-Vagedes, Ohlmeier, and
Dillo (2015) found co-occurring psychiatric disorders to be more common in older adults with
ASD without intellectual disability as compared to younger adults. On the other hand, a longterm follow-up study of 58 adults with autism found that informant ratings of poor mental health
were not associated with child or adult IQ or age (Moss, Howlin, Savage, Bolton, & Rutter,
2015). These inconclusive findings point to the need for further research into potential mediators
and moderators of the occurrence of psychiatric comorbidity in this population.
Several studies have found high rates of depression and anxiety in individuals with ASD
(Buck et al., 2014; Cassidy et al., 2014; Hofvander et al., 2009; Lugnegard, Hallerback, &
Gillberg, 2011), with rates that are greater than that seen in the general population (Croen et al.,
2015; Joshi et al., 2013; Wigham, Barton, Parr, & Rodgers, 2017). Estimates taken from
systematic reviews suggest that up to 60 percent of adults with ASD meet criteria for an anxiety
disorder (Croen et al., 2015; Joshi et al., 2013; Uljarevic et al., 2018), rates which exceed those
found in Down syndrome (Evans, Canavera, Klinepeter, Taga, & Maccubbin, 2005), specific
language impairment (Gillott, Furniss, & Walter, 2001), and Williams syndrome (Rodgers, Riby,
Janes, Connolly, & McConachie, 2012). Similarly, rates of depression in adults with ASD have
been estimated to be as high as 50 to 70 percent (Lugnegard, Hallerback, & Gillberg, 2011;
Wigham et al., 2017). A recent meta-analysis of the prevalence of depressive disorders in
children, adolescents, and adults with ASD by Hudson, Hall, and Harkness (2018) found that the
pooled lifetime prevalence rate was 14.4 percent and the pooled current prevalence rate was 12.3
percent. Further, results indicated that individuals with ASD are four times more likely to
experience depression in their lifetime compared to typically developing individuals (Hudson,
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Hall, & Harkness, 2018). Overall, the extant literature demonstrates that a majority of adults with
ASD meet diagnostic criteria for at least one psychiatric condition, with anxiety and depression
being the most commonly co-occurring psychiatric disorders in adults with ASD after attentiondeficit/hyperactivity disorder (Lever & Geurts, 2016).
Attention-Deficit/Hyperactivity Disorder
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder
defined by age-inappropriate inattention, impulsivity, and hyperactivity (American Psychiatric
Association, 2013). For a diagnosis of ADHD to be made, significant symptoms must have onset
prior to age 12, be currently manifested in two or more settings, and reduce the individual’s
functioning. Alternative explanations for ADHD symptoms, including the presence of anxiety or
mood disorders, must be excluded for the diagnosis to be given (Adler, Faraone, Sarocco,
Atkins, & Khachatryan, 2019). Importantly, between 25 and 35 percent of children with ADHD
are also likely to meet criteria for major depression or an anxiety disorder (Biederman et al.,
2008; Carlson, Tamm, & Gaub, 1997; Pliszka, 2007). Adult ADHD is one of the most commonly
occurring disorders in the general population, with an estimated point prevalence of 4.4 percent,
and is highly comorbid with other psychiatric disorders (Kessler et al., 2005).
ADHD and ASD show a high degree of comorbidity, with 22 to 83 percent of children
with ASD having symptoms that satisfy criteria for ADHD (Ronald et al., 2008; Matson et al.,
2013), and an estimated 30 to 65 percent of children with ADHD having clinically significant
symptoms of ASD (Clark et al., 1999; Ronald et al., 2008). Despite this high comorbidity,
previous studies have indicated that children with ASD can be distinguished from children with
ADHD based upon symptom profiles (Luteijn et al., 2000; Hattori, Ogino, Abiru, Nakano, Oka,
& Ohtsuka, 2006; Mayes, Calhoun, Mayes, & Molitoris, 2012), with meaningful behavioral
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differences between groups in terms of nonverbal communication, sensory interests, repetitive
movements, and preoccupations.
Comorbidity of Depression and Anxiety
Depression and anxiety are known to be highly co-occurring conditions in the general
population (Mineka et al., 1998; Moffit et al., 2007). Moreover, research has consistently found
high correlations between depression and anxiety when measured on a continuum (Cannon &
Weems, 2006; Morgan, Wiederman, & Magnus, 1998). Subsequently, some have suggested that
the two may be merely differing expressions of the same underlying phenomenology (Burns &
Eidelson, 1998; Feldman, 1993). Specifically, it has been posited that depression and anxiety
may share the same diathesis (Barlow & Campbell, 2000; Clark & Watson, 1991).
Notwithstanding these high correlations, depression and anxiety can be reliably distinguished
from one another, with unique diagnostic aspects for each disorder (Beesdo, Pine, Lieb, &
Wittchen, 2010). For instance, the tripartite model, a common theory that seeks to explain the
common factors underlying anxiety and depression (Clark & Watson, 1991), posits that both
anxiety and depression share elements related to negative affect; however, anhedonia is unique to
depression, whereas physiologic arousal is unique to anxiety. Therefore, although both share
elements of internalizing behavior, depression and anxiety can be measured as unique constructs.
Anxiety
Anxiety disorders are the most common mental health diagnosis in the United States,
affecting nearly one in five American adults age 18 and older (US Department of Health and
Human Services, 2016). Based on diagnostic interview data from the National Comorbidity
Study Replication (NCS-R), an estimated 19.1 percent of adults in the United States had any
anxiety disorder in the past year, and 31.1 percent experience any anxiety disorder at some point
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in their lives (Harvard Medical School, 2007). Anxiety disorders are characterized by features of
excessive anxiety and related behavioral disturbances, which cause clinically significant distress
in social, academic, occupational, or other areas of functioning (American Psychiatric
Association, 2013). High prevalence of anxiety disorders has been linked to low levels of
education, low income, and unemployment (Michael, Zetsche, & Margraf, 2007). Anxiety also
has a considerable impact on society in terms of decreased work productivity and increased
health care utilization (Wittchen, 2002). The annual cost of anxiety disorders was estimated at
$42 to $47 billion in the United States in 1990 (Greenberg et al., 1999; Rice & Miller, 1998).
Consequently, anxiety disorders can have a measurable impact, both in a personal and in a
societal sense.
Depression
The World Health Organization has recognized depression as the leading cause of
disability worldwide, ranking as the single largest contributor to non-fatal health loss (World
Health Organization [WHO], 2017). The 2016 National Survey on Drug Use and Health
(NSDUH; Center for Behavioral Health Statistics and Quality, 2017) indicated that an estimated
16.2 million adults in the United States had at least one major depressive episode, representing
6.7 percent of all adults in the United States. Depressive disorders are characterized by sadness,
loss of interest or pleasure, feelings of guilt or low self-worth, disturbed sleep or appetite, and
poor concentration (American Psychiatric Association, 2013). Depression can be long lasting or
recurrent, and thus can substantially impair an individual’s ability to function in daily life (WHO,
2017). Depression is associated with higher rates of chronic disease and increased health care
utilization (Katon, 2003; Wells et al., 1989). Most individuals with major depressive disorder
report some sort of role impairment associated with their depression, including impairment in
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home, work, relationship, and social domains (Kessler et al., 2003). Depression may have an
adverse effect on health habits such as smoking, diet, overeating, and having a sedentary
lifestyle, thus contributing to the incidence of additional medical conditions (Goodman &
Whittaker, 2002; Rosal et al., 2001). Indeed, evidence suggests that both depressive symptoms
and major depression may be associated with increased morbidity and mortality from illnesses
such as diabetes and heart disease (Katon, 2003).
Depression is also one of the largest contributors to suicide (Arsenault-Lapierre, Kim, &
Turecki, 2004; Bradvik, Mattisson, Bogren, & Nettelbladt, 2010; Lonnqvist, 2000). Suicide was
the tenth leading cause of death overall in the United States in 2016, claiming the lives of nearly
45,000 people (National Center for Injury Prevention and Control, 2016). Given the high burden
of disease inherent to depression, the US Preventive Services Task Force has recommended
screening for depression in the general adult population, given that systems are in place to ensure
accurate diagnosis, treatment, and follow-up (Siu et al., 2016). As follows from these
recommendations, it is imperative that these systems are effective and available; however, the
extant literature indicates that substantial gaps persist in the treatment of depression, with a
majority of United States adults who screened positive for depression not having received
treatment (Olfson, Blanco, & Marcus, 2016).
Anxiety and Depression in ASD
Several symptoms of ASD may share features with symptoms of depression and anxiety
disorders. For instance, social avoidance and withdrawal, commonly seen in individuals with
anxiety, may also be an expression of the social communication impairments that are common to
ASD (Uljarevic et al., 2018). Similarly, common symptoms of depression, such as reduced eye
contact and decreased communication of affect through facial expression or intonation, may be

8

masked by existing symptoms of ASD (Stewart, Barnard, Pearson, Hasan, & O’Brien, 2006). It
is also possible that the converse is true, in that social affect-related symptoms of depression may
mask underlying symptoms of ASD, though this hypothesis remains untested. These similarities
in clinical presentation may make anxiety and depression more difficult to detect in this
population. Ghaziuddin, Ghaziuddin, and Greden (2002) point out that diagnosing depression
can be particularly difficult in individuals with severe cognitive or communication impairments,
given that the diagnosis of depression often relies on the ability to recognize one’s own
emotional state and to verbally express that emotional state. Recognition and expression of one’s
emotional state poses challenges for many individuals with autism, some of whom may have
difficulty inferring the mental or emotional states of others or even themselves (Baron-Cohen,
1991; Mazefsky & Oswald, 2007). Because assessment of anxiety and depression is often reliant
on self-report, this may present additional complications in those with limited insight or verbal
aptitude. In such cases, attention to behavioral changes or informant reports may be helpful. For
instance, increased aggression, self-injurious behavior, and irritability, as well as decreased selfcare, sleep difficulties, or weight changes have been noted in the onset of depression in
individuals with ASD (Magnuson & Constantino, 2011). Similarly, an increase in repetitive or
compulsive behaviors or reactions to sensory stimuli may be associated with anxiety disorders in
those with ASD (Rodgers et al., 2016). Nonetheless, it remains largely unknown to what extent
these behaviors are a direct result of the underlying mood or anxiety disorder.
On the other hand, symptoms of ASD may contribute to the incidence of depression and
anxiety. For instance, the social difficulties inherent to ASD may result in elevated loneliness
and social isolation (Bauminger & Kasari, 2000; White & Roberson-Nay, 2009), both of which
have been shown to predict depression among typically developing adults (Cacioppo, Hughes,
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Waite, Hawkley, & Thisted, 2006). This relationship is not specific to typical development, as
other research has supported the link between negative affect and the poor quality of social
relationships in ASD (Whitehouse, Durkin, Jaquet, & Ziatas, 2009). Similarly, it is possible that
associated characteristics of ASD, such as social skill deficits or sensory sensitivities, contribute
or predispose to anxiety in this population (Bejerot, Eriksson, & Mortberg, 2014; Ben-Sasson et
al., 2008; Farrugia & Hudson, 2006). Indeed, in his original description of autism, Leo Kanner
(1943) hypothesized that the restricted and repetitive behavior of the children could be driven by
anxiety. Others have suggested that ASD may increase vulnerability to anxiety as a result of the
increased life stressors experienced by those with ASD (Gillott & Standen, 2007), as well as
difficulties regulating emotion and arousal that are common in this population (Bellini, 2006).
Importantly, however, it remains unknown to what extent anxiety results from ASD
symptomatology, accompanies it, or arises from an alternate pathway (Kerns & Kendall, 2012).
Kerns et al. (2014) assessed traditional and atypical presentations of anxiety in youth with
ASD. With regard to atypical anxiety, individuals with ASD may exhibit anxiety that is
associated with the characteristic features of ASD, such as excessive worry about circumscribed
topics, including changes in schedule or the environment, or fears focused on perseverative or
restricted behaviors, such as keeping sleeves rolled down or eating food of only one color (Kerns
et al., 2014). Traditional anxiety disorders were found in 17 percent of their sample, whereas
atypical anxiety was found in 15 percent of the sample; 31 percent of the sample presented with
both traditional and atypical anxiety. The authors’ findings confirm the idea that anxiety is a true
comorbidity among individuals with ASD, in that many co-occurring anxiety symptoms
appeared to be distinct from associated features of ASD such as compulsions and social
avoidance, thus providing support for the idea that some of these symptoms may reflect a distinct
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manifestation of anxiety in ASD. However, Kerns et al. (2014) note that a definitive answer
regarding the co-occurrence of anxiety and ASD is not possible, as there is a lack of validated
diagnostic instruments with which to make these conclusions.
Validity and Reliability of Measurement Instruments
Research on the validity and reliability of standardized measures of anxiety and
depression within the ASD population is limited, with few studies undertaking analyses of these
constructs in a non-neurotypical sample. One cannot assume to measure a phenomenon of
interest in a particular group accurately if measures have not been normed using members of that
group, as this may pose a threat to validity and thus hinder the utility of that assessment (Hays &
Wood, 2017).
Validity refers to the degree to which an instrument measures the construct it purports to
measure (Mokkink et al., 2010b). Validity can be further delineated into content validity,
construct validity, and criterion validity. Content validity refers to the degree to which the items
of the instrument adequately reflect the construct to be measured (Scholtes, Terwee, & Poolman,
2011). Construct validity estimates the degree to which scores on an instrument are consistent
with hypotheses, such as those regarding the relationships to other instruments of similar
constructs (convergent validity) or instruments of dissimilar constructs (discriminant validity), as
well as differences between relevant groups (Mokkink et al., 2010b). Finally, criterion validity
refers to the strength of the relationship between measures intended to predict an ultimate
criterion of interest and the criterion measure itself (Salkind, 2010). Relatedly, reliability can be
defined as the degree to which an instrument is free from measurement error, or the consistency
of scores from one assessment to another (Scholtes, Terwee, & Poolman, 2011). In this manner,
reliability is a necessary, although not sufficient, component of validity, in that an instrument
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that does not yield reliable scores cannot yield valid interpretations (Cook & Beckman, 2006).
Internal consistency is a specific type of reliability, which assesses the degree of interrelatedness
amongst individual items (Mokkink et al., 2010b). Subsequently, internal consistency assumes
that items are part of one underlying construct (Scholtes, Terwee, & Poolman, 2011). In other
words, internal consistency can be defined as the extent to which all the items of an instrument
measure the same construct (Tang, Cui, & Babkeno, 2014).
Measurement of Anxiety and Depression in Individuals with ASD
There is a need to examine whether and to what degree common measures of anxiety and
depression are able to assess these same constructs in individuals with ASD, in order to establish
the reliability and validity of these measures in the ASD population. Several studies have
examined the psychometric properties of such measures in children with ASD, with relatively
fewer studies examining these constructs in adults with ASD.
Sterling et al. (2015) examined the Revised Children’s Anxiety and Depression Scale
(RCDAS; Chorpita et al., 2005) in a sample of 67 youth with autism spectrum disorders ranging
in age from 11 to 15 years who also met criteria for an anxiety disorder. In addition to the
RCDAS, other standardized measures of anxiety and depression, including the Anxiety
Disorders Interview Schedule (ADIS-IV-C/P; Silverman & Albano, 1996), Child Behavior
Checklist (CBCL; Achenbach, 2001), Multidimensional Anxiety Scale for Children—Parent
(MASC-P; March, 1997), and the Pediatric Anxiety Rating Scale (PARS; Research Units on
Pediatric Psychopharmacology Anxiety Study Group, 2002), were examined. Internal
consistency of the RCADS was acceptable, with Cronbach’s alpha ranging from .72 to .93. To
measure concurrent validity of the RCADS Total Anxiety and Total Internalizing scores,
correlations were conducted with total scores on the ADIS, CBCL, MASC-P, and the PARS.
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Total scores on the RCADS correlated with PARS total scores and with the CBCL
Anxiety/Depression scale, indicating that the RCADS could potentially be a useful tool for selfreport of anxiety and depression among youth with ASD. To examine divergent validity,
correlations were examined between RCADS Total scores and subscales of the CBCL and the
Autism Diagnostic Observation Schedule (ADOS; Lord et al., 2002) that were not expected to be
related. None of the relationships was significant, with the exception of the Attention Problems
subscale of the CBCL, which had significant correlations with both the RCADS Total Anxiety
and Total Internalizing scores, which the authors posit may be a result of the role of attention in
regulating emotional impulses. Overall, results of Sterling et al. (2015) indicate that the RCADS
may be useful in detecting depression and anxiety in youth with ASD; however, more
convincing evidence, such as that produced by factor analysis, is needed.
A small body of literature has examined the invariance of self-report measures in
individuals with ASD using factor analytic methods. Factorial invariance refers to the
consistency of a factor model across different groups (Dimitrov, 2010). Establishing factorial
invariance involves a hierarchy of nested levels that include tests of configural, metric (weak
factorial invariance), scalar (strong factorial invariance), and strict factorial invariance (Meredith
& Teresi, 2006). Configural invariance tests whether the pattern of free and fixed model
parameters is the same across groups (Dimitrov, 2010). At the level of metric invariance, equal
factor loadings are required across groups (Dimitrov, 2010). Scalar invariance tests whether there
are equal item intercepts across groups (Dimitrov, 2010). Finally, strict factorial invariance
establishes that equal item error variances and covariances exist across groups, such that group
differences on any item are due only to differences on the common factors (Dimitrov, 2010).
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White et al. (2015) examined the factor equivalence of anxiety as measured by the
Multidimensional Anxiety Scale for Children (MASC; March, 1997) in youth with ASD and cooccurring anxiety disorders and a gender-matched comparison group of typically developing
children with anxiety disorders. The authors examined both the parent report (MASC-P) and the
child self-report (MASC-C) versions for factor invariance. White et al. (2015) hypothesized that
the MASC-P would demonstrate metric invariance but that the MASC-C data would not.
Confirmatory factor analysis using structural equation modeling was conducted on the MASC-P
and the MASC-C in the combined sample to ensure sufficient fit to test invariance. Evidence was
found for metric invariance of the MASC-C across the two groups, suggesting that the original
factor structure was replicable in both groups at a broad level, with the same latent factors
emerging. However, scalar invariance was not supported across the two groups, indicating that
the factors do not relate to each other in the same way as they do in typically developing youth.
White et al. (2015) concluded that the MASC-C may not be an appropriate tool for assessment of
anxiety in youth with ASD and cautioned against its use with such populations.
Uljarevic et al. (2018) examined the psychometric properties of the Hospital Anxiety and
Depression Scale (HADS; Zigmond & Snaith, 1983) in a sample of 151 adolescents and young
adults with ASD. The HADS is a norm-referenced questionnaire used to assess anxiety and
depression in community and non-psychiatric populations. Uljarevic and colleagues examined
the HADS for latent components using principal components analysis with direct oblimin
rotation. Two factors—interpretable as Anxiety and Depression—emerged, accounting for 43.77
percent of variance. All items loaded in the same way as originally designed by Zigmond and
Snaith (1983). Internal consistency was good for the HADS-Anxiety scale (alpha = .83) and
acceptable (alpha = .65) for the HADS-Depression scale. The authors also examined convergent
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validity by comparing the HADS to the Strengths and Difficulties Questionnaire (Goodman,
Meltzer, & Bailey, 1998), the Warwick-Edinburgh Mental Well-being Scale (Clarke et al.,
2011), the DSM-5 Dimensional Anxiety Scales (LeBeau et al., 2012), and the Patient Health
Questionnaire-9 (PHQ-9; Kroenke & Spitzer, 2002). There were medium to large negative
associations between the HADS-Anxiety and HADS-Depression scales with the WarwickEdinburgh Mental Well-being Scale (r = -.45 and r = -.60, respectively), as well as medium to
large positive correlations between the HADS-Anxiety and HADS-Depression scales and the
emotional scale of the Strengths and Difficulties Questionnaire (r = .80 and r = .29.
respectively). Additionally, there was a large positive correlation between the HADS-Anxiety
scale and the DSM-5-Dimensional Anxiety Scale (r = .71) and a medium correlation between the
HADS-Depression scale and the PHQ-9 (r = .56). Divergent validity of the HADS was also
acceptable, as demonstrated by non-significant correlations with chronological age and ASD
severity as measured by the Social Responsiveness Scale (SRS; Constantino & Gruber, 2005)
and the abridged Autism-Spectrum Quotient (AQ-Short; Hoekstra et al., 2011). Taken together,
the results of Uljarevic et al. (2018) suggest that the HADS provides a reliable and valid
assessment of anxiety and depression in older adolescents and adults with ASD.
Gotham, Unruh, and Lord (2015) examined response patterns and associations between
scores on common measures of depressive symptoms in a sample of 50 verbally fluent
adolescents and adults with ASD, ranging from age 16 to 31 years. Participants completed the
BDI-II (Beck, Steer, & Brown, 1996), a self-report questionnaire that measures emotions related
to depression, somatic symptoms, and lifestyle changes; the Self-Report Depression
Questionnaire (SRDQ; Reynolds & Baker, 1988), a questionnaire designed to measure physical,
cognitive, and behavioral aspects of depression in adults with mild to moderate intellectual
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disability; and the Adult Self-Report (ASR; Achenbach & Rescorla, 2003), a measure that
assesses a variety of symptoms, which contribute to Internalizing and Externalizing scales.
Parents of participants completed the Children’s Depression Rating Scale (CDRS; Poznanski &
Mokros, 1996), the CDI—Parent-Rated Version (CDI-P; Kovacs, 1992), and the Adult Behavior
Checklist (ABCL; Achenbach & Rescorla, 2003). Scores on the various depression measures
were not associated with chronological age or verbal IQ, which ranged from 72-140 in their
sample. Internal consistency was acceptable to strong for the BDI-II (alpha = .97), CDI-P (alpha
= .73), and the CDRS (alpha = .85). The authors indicated that their results provide support for
the use of self-report measures for depression within verbally fluent individuals with ASD.
Cassidy, Bradley, Bowen, Wigham, and Rodgers (2018) undertook a systematic review
of the literature surrounding tools used to assess depression in adults with and without ASD. The
authors first searched the literature for all available studies that utilized a tool to assess
depression frequently (at least twice) with evidence of validity in adults with ASD without
intellectual disability and adults from the general population without co-morbid conditions. Six
tools were identified based on the above criteria and were considered further: the Hamilton
Rating Scale for Depression (HRSD; Hamilton, 1960); Montgomery Asberg Depression Rating
Scale (MADRS; Montgomery & Asberg, 1979); Beck Depression Inventory-Second Edition
(BDI-II; Beck, Steer, & Brown, 1996); Center for Epidemiological Studies Depression ScaleRevised (CESD-R; Eaton, Smith, Ybarra, Muntaner, & Tien, 2004); Patient Health
Questionnaire (PHQ-9; Kroenke & Spitzer, 2002); and the Zung Self Rating Depression Scale
(ZDS; Zung, 1965). In comparison to the general population, there were few studies that used
validated tools to assess depression in adults with ASD, and none that used a tool validated
specifically for ASD.
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Cassidy et al. (2018) used The Consensus Based Standards for the Selection of Health
Measurement Instruments (COSMIN; Mokkink et al., 2010a), a checklist that assesses the
evidence for the appropriateness and measurement properties of an instrument. COSMIN rates
the evidence in support of nine measurement properties (internal consistency; reliability;
measurement error; content validity; structural validity; hypothesis testing; criterion validity;
responsiveness to change; and cross-cultural validity) on a 4-point scale. The BDI-II and the
PHQ-9 were identified as having robust evidence for a range of these properties in general
population adults; only one study explored the psychometric properties of a validated depression
tool (BDI-II) in adults with ASD (Gotham, Unruh, & Lord, 2015), finding it to possess strong
internal reliability in a sample of adolescents and adults with ASD. Cassidy et al. (2018)
highlight the need for future research studies to explore the validity of depression measures in
adults with ASD to ensure that items relate to the relevant construct to be measured.
Goals of the Study
The present study seeks to determine whether the psychometric properties and factor
structure of two self-report measures of internalizing symptoms—the Depression Anxiety Stress
Scales-21 (DASS-21; Lovibond & Lovibond, 1995) and the Center for Epidemiologic Studies
Depression Scale, Revised (CESD-R; Eaton et al., 2004)—are equivalent in adults with high and
low levels of autistic traits. Previous research has indicated that the autism spectrum is a
heterogeneous construct, with its component traits distributed across the population (Rai et al.,
2018); therefore, these traits can be measured on a continuum and used to categorize individuals
into groups. The CESD-R is one of the most widely used instruments in the field of psychiatric
epidemiology, particularly with regard to depression research (Eaton & Kessler, 1981; Murphy,
2002). It possesses excellent psychometric properties within the general population (Van Dam &
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Earleywine, 2011), but has never been investigated in the population of adults with autism. Like
the CESD-R, the DASS measures depression, but it also examines the constructs of anxiety and
stress, providing a broader assessment of internalizing symptoms. Nah, Brewer, Young, and
Flower (2018) used the DASS as a screening measure for anxiety and depression in a sample of
155 adults with autism; however, its psychometric properties were not examined in this sample
nor in previous research. In addition, the World Health Organization (WHO) Adult ADHD SelfReport Scale (ASRS; Kessler et al., 2005) will be examined as a measure of divergent validity.
As the ASRS, CESD-R, and DASS are all self-report instruments, they use respondents’ own
perceptions as the source of data. In addition, because the ASRS, CESD-R, and DASS are in the
public domain, they can be completed quickly and do not pose a significant cost to users.
Consequently, the current study will investigate the factorial invariance of these measures in a
large sample of adults.
Factorial Invariance
Measurement invariance refers to “whether or not, under different conditions of
observing and studying phenomena, measurement operations yield measures of the same
attribute” (Horn & McArdle, 1992, p. 117). Measurement invariance is a prerequisite to
establishing factorial invariance (Ollendick & White, 2012). Relatedly, factorial invariance refers
to whether the same construct is being measured across groups or across time. One can consider
factorial invariance to have four levels, each of which adds additional constraints to the
preceding level: configural invariance, metric (weak factorial) invariance, scalar (strong
factorial) invariance, and strict factorial invariance (Meredith, 1993). Configural invariance
refers to whether the same factor model specification holds across groups; metric invariance
requires cross-group equality in factor loadings; scalar invariance requires cross-group equality
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in factor loadings and intercepts; and strict factorial invariance requires cross-group equality in
factor loadings, intercepts, and residual variances (Wu, Li, & Zumbo, 2007). In this manner,
configural invariance assesses whether there are similar latent factors across groups, whereas
strict factorial invariance assesses whether there is an identical item structure in both groups
(White et al., 2015).
Study Hypotheses
The current study examines the factorial invariance of the ASRS (Kessler et al., 2005),
CESD-R (Eaton et al., 2004) and DASS-21 (Lovibond & Lovibond, 1995) across two groups of
adults: those with a) high levels and b) low levels of autistic traits, as measured by the Autism
Spectrum Quotient (AQ; Baron-Cohen, Wheelwright, Skinner, Martin, & Clubley, 2001), a well
validated self-report instrument which quantifies autistic traits in adults. It is hypothesized that
neither the CESD-R nor the DASS-21 will demonstrate metric invariance across groups. Metric
invariance suggests that the same latent constructs are being measured across groups, with any
differences in covariances of observed items able to be attributed to latent factors (White et al.,
2015). The hypothesis that metric invariance will not hold for the DASS-21 and the CESD-R
follows from the idea that traditional measures of anxiety and depression may not capture the
presentation of these constructs in individuals with ASD, whether this is due to diagnostic
overshadowing, difficulty interpreting and reporting emotions, or another pathway (Cassidy et
al., 2018; Mazzone, Ruta, & Reale, 2012).
In the group of adults with high levels of autistic traits, it is hypothesized that data from
the CESD-R and the DASS-21 will not possess the same factor model specifications as
established in general (Eaton, Smith, Ybarra, Muntaner, & Tien, 2004; Lovibond & Lovibond,
1995; Van Dam & Earleywine, 2011) and clinical (Antony, Bieling, Cox, Enns, & Swinson,
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1998; Brown, Chorpita, Korotitsch, & Barlow, 1997) adult populations. In addition, it is
hypothesized that convergent validity will be demonstrated between the CESD-R and the
Depression scale of the DASS-21, as evidenced by significant correlation coefficients.
Third, it is hypothesized that ADHD symptoms as measured by the ASRS will be
divergent from depression and anxiety symptoms, as measured by the CESD-R and the DASS21, given the different constructs assessed within the ASRS (i.e., inattention and hyperactivityimpulsivity) as opposed to the other two self-report measures.
Finally, it is hypothesized that anxiety will be divergent from depression both within and
between self-report measures among the group of adults with low levels of autistic traits, but not
within the group of adults with high autistic traits, given the potential for greater diagnostic
overshadowing within ASD populations.
Method
Participants
Approval from the Institutional Review Board of Syracuse University was attained before
commencement of the study. Electronic informed consent was obtained from all study
participants. Participants were required to enter the date on which they completed the survey to
formalize their agreement to participate in the study. This was a convenience sample of
participants who responded to a survey posted on Amazon Mechanical Turk, an online labor
market. All participants were recruited through Human Intelligence Tasks (“HITs”) posted on
Amazon Mechanical Turk titled “Answer a survey about your mood, emotions, and behavior.”
The description of the survey was listed as “Answer questions designed to understand how
people think, feel, and behave in everyday life.” Accompanying keywords were “survey,”
“research,” and “psychology.”
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Participants were adults located within the United States who were of at least 18 years of
age. Individuals located outside the United States were restricted from participation given that
study measures were normed using data collected within the United States, and all study
materials were in English. Additionally, the constructs of depression and anxiety might differ
cross-culturally, in a way that may not be captured adequately by the CESD-R and the DASS-21
(Byrne & Campbell, 1999; Byrne & van de Vijver, 2010; Chen, 2008). In addition to completion
of the psychological measures, participants completed questions about demographic information
including age, gender, and race/ethnicity.
Measures
World Health Organization Adult ADHD Self-Report Scale
The World Health Organization (WHO) Adult ADHD Self-Report Scale (ASRS; Kessler
et al., 2005) is a self-report screening scale of adult attention-deficit/hyperactivity disorder that
was developed in conjunction with the revision of the WHO Composite International Diagnostic
Interview. The ASRS consists of 18 questions regarding the frequency of Diagnostic and
Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV-TR; American Psychiatric
Association, 2000) symptoms of ADHD. Respondents are asked to use a 5-item Likert scale to
indicate the frequency of occurrence of symptoms over the last six months, with answer
categories of “never,” “rarely,” “sometimes,” “often,” and “very often.” The ASRS consists of
two subscales, Inattention and Hyperactivity-Impulsivity, each consisting of 9 items. The total
sum of the ASRS ranges from 0 to 72.
The ASRS has demonstrated good reliability and validity in both clinical and population
samples (Adler et al., 2006; Silverstein et al., 2018; van de Glind et al., 2013; Vildalen et al.,
2016). In previous studies, the ASRS has been shown to have moderate sensitivity, high
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specificity, and high total classification accuracy, with values of .56, .98, and .96, respectively
(Kessler et al., 2005).
In the normative sample, the ASRS possessed good internal consistency, with a
Cronbach’s alpha value of 0.88 in a sample of 60 adults evaluated for ADHD. In an independent
analysis, Vildalen et al. (2019) reported Cronbach’s alpha values of .93 for inattention and .91
for hyperactivity/impulsivity, with almost identical values for females (.93 and .91) and males
(.92 and .91), in a sample of 1,564 adult participants. In addition, ASRS scores have been shown
to be stable cross-culturally with Hungarian (Farcas et al., 2018), Israeli (Zohar & Konfortes,
2010), Korean (Kim, Lee, & Joung, 2013), and Taiwanese (Yeh et al., 2008) samples.
Autism-Spectrum Quotient
The Autism-Spectrum Quotient (AQ; Baron-Cohen, Wheelwright, Skinner, Martin, &
Clubley, 2001) is a self-administered questionnaire that assesses the degree to which an
individual without intellectual disability possesses traits associated with the autism spectrum.
The AQ consists of 50 items assessing personal preferences and habits, divided into five
subscales of 10 items each: social skill; communication; imagination; attention to detail; and
attention switching. Individuals are asked to rate to what extent they agree or disagree with the
statements (e.g., “I notice patterns in things all the time”; “I find social situations easy”) on a 4point Likert scale, with answer categories of “definitely agree,” “slightly agree,” “slightly
disagree,” and “definitely disagree.” Approximately half of items are worded to produce an
‘agree’ response, and half a ‘disagree’ response, in order to avoid response bias. Each item is
scored one point if the respondent endorses the behavior associated with ASD (i.e., poor social
skill, poor communication skill, poor imagination, exceptional attention to detail, poor attentionswitching/strong focus of attention).
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The AQ has demonstrated utility in distinguishing individuals who have clinically
significant levels of autistic traits, and AQ sum scores are normally distributed in the general
population (Hurst, Mitchell, Kimbrel, Kwapil, & Nelson-Gray, 2007). An AQ total score of 32 is
the recommended cutoff for use in the general population, as 79.3 percent of a group of adults
with Asperger syndrome or high-functioning autism scored at this level compared to 2 percent of
controls (Baron-Cohen et al., 2001). Although not a diagnostic instrument, the AQ has
demonstrated diagnostic validity, with good discriminative validity and screening properties
using a threshold score of 26 (Woodbury-Smith, Robinson, Wheelwright, & Baron-Cohen,
2005).
With regard to internal consistency, Cronbach’s alpha coefficients were moderate to
acceptable for all domains (Communication = .65; Social skill = .77; Imagination = .65;
Attention to detail = .63; Attention switching =.67). In an independent analysis, Austin (2005)
reported similar findings (Communication = .61; Social skill = .75; Imagination = .65; Attention
to detail = .66; Attention switching = .58), as well as a coefficient alpha of .82 for the total AQ
score. Test-retest coefficients were r = .7 in a sample of 17 university students who completed a
second AQ two weeks after a first administration (Baron-Cohen et al., 2001). In addition, AQ
scores have been shown to be stable cross-culturally with Japanese (Kurita, Koyama, & Osada,
2005; Wakabayashi, Baron-Cohen, Wheelwright, & Tojo, 2006) and Dutch samples (Hoekstra,
Bartels, Cath, & Boomsma, 2008).
Center for Epidemiologic Studies Depression Scale-Revised
The Center for Epidemiologic Studies Depression Scale-Revised (CESD-R; Eaton,
Smith, Ybarra, Muntaner, & Tien, 2004) is a self-report scale used to assess symptoms of
depression in the general population. The CESD-R is an updated version of the Center for
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Epidemiologic Studies Depression Scale (CES-D; Radloff, 1977), which was originally
composed of four factors: depressed affect, absence of positive affect, somatic activity/inactivity,
and interpersonal difficulties. The CES-D was revised to reflect the primary symptoms of a
major depressive episode according to criteria from the Diagnostic and Statistical Manual of
Mental Disorders, Fourth Edition (DSM-IV-TR; American Psychiatric Association, 2000). In
comparison to the CES-D, the CESD-R includes an extra response category (nearly every day for
two weeks), as well as additional items reflecting anhedonia, psychomotor retardation/agitation,
and suicidal ideation. The CESD-R consists of 20 items, which correspond to the nine cardinal
symptoms of major depressive disorder as conceptualized by the DSM: sadness (dysphoria); loss
of interest (anhedonia); appetite; sleep; thinking/concentration; guilt (worthlessness); tired
(fatigue); movement (agitation); and suicidal ideation. Respondents are asked to select how often
they have felt this way during the past week, with five response options: “not at all or less than 1
day”; “1-2 days”; “3-4 days”; “5-7 days”; or “nearly every day for 2 weeks.” The total CESD-R
score is calculated as the sum of responses to all 20 questions. Total CESD-R scores range
between zero (for those who respond “not at all or less than 1 day” to all questions) and 60 (for
those who respond “5-7 days” or “nearly every day for 2 weeks” to all questions). Scores greater
than or equal to 16 indicate that the respondent is at risk for clinical depression (Radloff, 1977).
The CESD-R has been validated in several samples (Eaton et al., 2004; Van Dam &
Earleywine, 2011). The CESD-R possessed excellent internal consistency across these studies,
with alpha ranging from .90 to .93. Item-total correlations ranged from .32 to .75 in a sample of
nurse assistants (Eaton et al., 2004). The overall correlation between the original CESD and the
CESD-R in this sample was .88, which suggests that the two scales are measuring the same
construct. The CESD-R also demonstrated theoretically consistent convergent and divergent
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validity with anxiety, schizotypy, and positive and negative affect (Van Dam & Earleywine,
2011). Van Dam and Earleywine (2011) performed both exploratory and confirmatory factor
analyses, finding that a two-factor model fit the data significantly better than a one-factor
solution in two samples; however, the inter-factor correlation was .941 in sample 1 and .975 in
sample 2, suggesting factor redundancy.
Depression Anxiety Stress Scales
The Depression Anxiety Stress Scales (DASS; Lovibond & Lovibond, 1995) are a set of
self-report scales designed to measure the magnitude of three negative emotional states:
depression, anxiety, and stress. Two versions, one with 42 items and one with 21 items, of the
DASS are offered, with the DASS-21 (Lovibond & Lovibond, 1995) consisting of a subset of
items from the DASS. Each of the three scales consists of either 14 or 7 items, divided into
subscales of similar content. The Depression scale assesses dysphoria, hopelessness, devaluation
of life, lack of interest/involvement, anhedonia, inertia, and self-deprecation. The Anxiety scale
assesses autonomic arousal, skeletal musculature effects, situational anxiety, and the subjective
experience of anxious affect. The Stress scale assesses difficulty relaxing, nervous arousal, being
easily agitated, easily irritable, or impatient. The individual is asked to use a 4-point scale to rate
the extent to which they have experienced each symptom over the past week.
Internal consistencies for each scale for the DASS normative sample were good to
excellent, with a coefficient alpha of .91 for Depression, .84 for Anxiety, and .90 for Stress
(Lovibond & Lovibond, 1993). Norton (2007) assessed the psychometric properties of the
DASS-21 among different racial groups, finding it to possess adequate internal consistency
(coefficient alphas ranging from .78 to .87) across groups. Similarly, the DASS-21 has evidence
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of good convergent and discriminant validity when compared to other measures of depression
and anxiety (Henry & Crawford, 2005).
The DASS has also been examined in outpatient samples of individuals presenting for
assessment and treatment of anxiety and mood disorders. Test-retest reliability was assessed in a
group of 20 patients who were re-administered the DASS two weeks after their initial evaluation.
All three scales of the DASS evidenced temporal stability, with test-retest coefficients of .713,
.785, and .813 for Depression, Anxiety, and Stress, respectively (Brown, Chorpita, Korotitsch, &
Barlow, 1997). In addition, exploratory factor analysis with principal components extraction
suggested a three-factor solution (Antony, Bieling, Cox, Enns, & Swinson, 1998), in fitting with
Lovibond and Lovibond (1995). Studies that have directly compared the full DASS and the
DASS-21 in clinical populations suggest that the DASS-21 is associated with a cleaner factor
structure relative to the DASS-42 (Antony et al., 1998; Clara, Cox, & Enns, 2001). Taken
together, these results provide support for the validity of the DASS in clinical populations.
Procedure
Participants used Amazon’s Mechanical Turk (MTurk; http://www.mturk.com/) to
complete the survey. MTurk is an online labor market created by Amazon designed to assist
“requesters” in hiring and paying “workers” for the completion of computer-based tasks, referred
to as “Human Intelligence Tasks” or “HITs.” Workers are paid by requesters upon successful
completion of HITs (Paolacci & Chandler, 2014). All MTurk workers are required to sign a
participation agreement electronically confirming that they are at least 18 years of age in order to
use the platform. Research has generally indicated that MTurk workers provide high-quality
data, as evidenced by equivalence to other data collection methods with regard to internal
consistency and test-retest reliability (Shapiro, Chandler, & Mueller, 2013).
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After accepting the HIT on MTurk, participants were redirected to a Qualtrics survey, in
which they completed demographic information questions, the ASRS, the AQ, the CESD-R, and
the DASS-21. Within the Qualtrics survey, each of the aforementioned survey elements was
randomly presented using block randomization, with each element presented roughly an equal
number of times across all respondents. To protect participants’ anonymity, all survey responses
were collected through Qualtrics. Specifically, Amazon has access to workers’ personal
identifiable information and survey responses (Mason & Suri, 2011) and automatically collects
Internet Protocol (IP) addresses for all participants, increasing the risk that data may be
identifiable. Upon completion of the survey, participants received a completion code, identical
for all participants, which was used for the purposes of compensation on the MTurk platform.
Participants were compensated $1.50 for completing the full survey consisting of
demographic questions, the ASRS, the AQ, the CESD-R, and the DASS-21. In order to achieve
an optimal number of participants across both the low ASD traits and high ASD traits groups, all
participants were screened using the AQ. Upon reaching 230 participants in the low ASD traits
group, survey respondents with an AQ score less than 26 were routed to the end of the survey,
and survey respondents with an AQ score greater than or equal to 26 were routed to complete all
study measures. Participants who were routed to complete only the AQ were paid $0.30, whereas
those who were routed to complete all study measures were paid $1.50.
Data for the present study were collected from April 2019 to October 2019 on MTurk.
During this period, 17 HITs were posted to MTurk consisting of 20 (5.9% of total HITs), 50
(76.5% of total HITs), or 100 assignments (17.6% of total HITs) per HIT. Each HIT reached its
total number of assignments in a minimum of 2 days and a maximum of 7 days. In total, 997
responses were collected. Of those 997 responses, 434 (43.5%) were included in the final
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sample. The 563 responses that were not included in the final sample comprised participants who
completed the AQ and then were routed to the end of the survey or who failed four out of four
attention checks (n = 3).
Power Analysis
The power of a test is its “sensitivity or ability to detect what is present” (Maxwell &
Delaney, 2004, p. 24). In other words, power is the probability of rejecting the null hypothesis
when it is false. A power analysis can provide further information regarding the likelihood that a
given experimental design will detect an effect of a particular size in a population (Maxwell &
Delaney, 2004). In this manner, one can use a power analysis to determine the sample size
necessary to provide an experiment with adequate power.
The minimum sample size required to achieve a power of .80 was calculated using the
statistical program R (R Core Team, 2018), with syntax generated from Preacher and Coffman
(2006). The program generated the minimum sample size needed to use the Root Mean Square
Error of Approximation (RMSEA; Steiger & Lind, 1980) to assess goodness of model fit within
structural equation modeling (MacCallum, Browne, & Sugawara, 1996). Alpha was set at .05,
with 190 degrees of freedom, corresponding to the number of potentially estimable parameters of
interest when conducting structural equation modeling on the CESD-R. A null RMSEA value of
.05 was specified as achieving adequate model fit, with an alternative RMSEA value of .08
signifying a poor model fit. In this sense, effect size in this approach is defined in terms of the
difference in overall fit of the two models, as indexed by the specified RMSEA values
(MacCallum, Browne, & Cai, 2006). The above analysis yielded a minimum of 87 participants
per group in order to achieve a power of .80.
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Importantly, however, the power analysis above does not take both groups (high and low
levels of autistic traits) into account, as it is unknown how many individuals with high autistic
traits exist in the population. Therefore, 87 participants per group can be considered a minimum
estimate of the number of participants needed for the proposed study. Sample size has a
considerable impact on both reliability and validity in the context of factor analysis (Kyriazos,
2018). Several guidelines have been suggested with regard to achieving adequate sample size for
use in a confirmatory factor analysis, including an N greater than 200 (Comrey, 1988); a ratio of
10 participants per indicator variable (Wang & Wang, 2012); or a ratio of 20 participants for
every parameter estimated (Jackson, 2003). Given that large samples are crucial for models with
accurate parameter estimates, particularly when normality assumptions are not met (MacCallum
et al., 1996), the present study adopted a more conservative sample size. Consequently, the
present study used quota sampling in an attempt to include a minimum sample size of 210
participants in each group (high and low levels of autistic traits) to align with the 21-item version
of the DASS, in fitting with the ratio of 10 participants for every indicator variable (Wang &
Wang, 2012). Consequently, participant data was split into two groups: those who have a high
level of autistic traits (total AQ score greater than or equal to 26) and those who have a low level
of autistic traits (total AQ score less than 26). This cut-off is in accordance with previous
research by Woodbury-Smith et al. (2005) as mentioned above, which indicated that the AQ
correctly identified 83 percent of patients in a referred clinical sample using a cut-off score of 26.
Data Analysis Strategy
Confirmatory factor analysis, using structural equation modeling in Mplus Version 8.4
(Muthen & Muthen, 2017), employing the standard CESD-R, DASS, and ASRS factor structure
was conducted in the combined sample for each measure to ensure sufficient fit to test
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invariance. The same confirmatory factor analysis was then run on the low ASD traits and high
ASD traits groups in multigroup invariance analyses. In all invariance models, the low ASD traits
group served as the reference group and the high ASD traits group served as the alternative
group.
Analyses began with the test of configural invariance, in which latent factor means were
constrained to be 0 and factor variance was fixed to 1 for identification within each group. All
other parameters were freely estimated. This tested whether the same pattern or factor structure
existed in both groups.
Next, the test for metric (weak factorial) invariance was conducted by constraining
loadings of observed items onto latent factors to be equal across both groups. Specifically, factor
variance was fixed to 1 in the low ASD traits group but was freely estimated in the high ASD
traits group, and factor means were fixed to 0 in both groups. Intercepts and residual variances
were permitted to vary across groups.
In addition to the constraints imposed by the test of metric invariance, the test of scalar
(strong factorial) invariance specified item intercepts to be equal across groups. Specifically,
factor means and variances were fixed to 0 and 1, respectively, for identification within the low
ASD traits group; factor means and variances were then estimated in the high ASD traits group.
Factor loadings and item intercepts were constrained to be equal across groups. Residual
variances were permitted to differ across groups.
Finally, the test of strict invariance constrained residual variances to be equal across
groups, in addition to the constraints imposed in the previous models. In particular, factor means
and variances were fixed to 0 and 1, respectively, for identification in the low ASD traits group;
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factor means and variances were estimated in the high ASD traits group. All factor loadings, item
intercepts, and residual variances were constrained to be equal across groups.
Results
Descriptive Statistics
Descriptive statistics were analyzed using JASP Version 0.9.01 (JASP Team, 2019), R (R
Core Team, 2017), and IBM SPSS Statistics for Windows Version 25.0 (IBM, 2017). The low
ASD traits group was compared to the high ASD traits group to assess differences on basic
demographic factors using univariate ANOVAs for continuous variables and χ2 tests for
categorical variables. Descriptive statistics for study variables and demographic factors are
presented in Table 1. There were no significant differences between groups with regard to age,
gender, native language, and race/ethnicity. Total scores on all study measures, including the
ASRS, AQ, CESD-R, and DASS, were significantly higher in the high ASD traits group.
Missing Data
Missing values were examined to determine patterns of missingness and the necessity of
subsequent analytical adjustments. Missing data analyses revealed a maximum level of
missingness at 2.99% (23 items), with all other items at < 2.8% missingness (M missing = 1.6%; SD
missing =

1.2%) and a minimum level of missingness of 0.23% (5 items). Little’s test indicated that

data were not missing completely at random [MCAR], χ2 (277) = 590.5, p < .001. Consequently,
the missingness pattern was explicitly examined in order to diagnose the missing data
mechanism. Investigation of the missingness pattern suggested that for items with the greatest
percent missing data (i.e., ≥ 2.5%), the pattern could be attributable to sample differences given
that data were missing by design. Specifically, in order to achieve an optimal number of
participants across both the low ASD traits and high ASD traits groups, all participants were
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screened using the AQ. Upon reaching 230 participants in the low ASD traits group, survey
respondents with an AQ score less than 26 were routed to the end of the survey, and survey
respondents with an AQ score greater than or equal to 26 were routed to complete all study
measures. Consequently, because the data that were missing by design could be said to be
missing at random [MAR], no model adjustments were made in subsequent factorial invariance
analyses.
Bivariate Correlations Within Study Measures
Correlation coefficients were calculated for all three self-report measures across both the
low ASD traits and high ASD traits groups as a measure of shared variance. Bivariate
correlations among study variables are presented in Tables 2-7. Importantly, most of the items of
the DASS-21 and all the items of the CESD-R demonstrated high skewness and kurtosis,
indicating a non-normal distribution for these data. Skewness and kurtosis values for all study
measures in the combined sample are presented in Table 8.
Inter-Item Correlations
Average inter-item correlation was calculated for each of the three measures as an
indicator of item redundancy. The overall CESD-R total score demonstrated medium to large
inter-item correlations in the low ASD traits (MIIC = .52) and high ASD traits (MIIC = .46) groups.
For the ASRS, inter-item correlations were medium to large for both the low ASD traits
(Inattention MIIC = .55; Hyperactivity-Impulsivity MIIC =.43) and high ASD traits (Inattention
MIIC = .42; Hyperactivity-Impulsivity MIIC =.33) groups. Similarly, for the DASS-21, inter-item
correlations were large in both the low ASD traits (Depression MIIC = .69; Anxiety MIIC =.57;
Stress MIIC =.60) and high ASD traits (Depression MIIC = .60; Anxiety MIIC =.54; Stress MIIC
=.50) groups.
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Bivariate Correlations Between Study Measures
All correlations between total scores and subscale scores for all measures were
significant. Bivariate correlations between subscale scores for the low ASD traits and high ASD
traits groups are presented in Table 9. Correlations between raw total scores for the CESD-R and
each of the DASS-21 subscales were strong for the overall sample (DASSDepression: r = .86;
DASSAnxiety: r = .73; DASSStress = .81). Correlations between raw total scores for the CESD-R
and the two subdomains of the ASRS were moderate to strong for the overall sample
(ASRSInattention: r = .59; ASRSHyperactivity-Impulsivity: r = .63). Correlations between raw total scores
for the ASRS and each of the DASS-21 subscales were moderate to strong for the overall sample
(ASRSInattention-DASSDepression: r = .60; ASRSInattention-DASSAnxiety = .51; ASRSInattention-DASSStress
= .61; ASRSHyperactivity-Impulsivity DASSDepression: r = .60; ASRSHyperactivity-Impulsivity-DASSAnxiety:
r=.65; ASRSHyperactivity-Impulsivity-DASSStress: r = .69).
Internal Consistency
As a measure of internal consistency, Cronbach’s alpha (Cronbach, 1951) was calculated
for each factor and the overall scale for each of the study measures using the formula α = (N*𝑐̅) /
𝑣̅ + (N – 1) * 𝑐̅, where N is equal to the number of items, 𝑐̅ is the average inter-item covariance
among item pairs, and 𝑣̅ is the average variance. Cronbach’s alpha estimates for each scale are
presented in Table 10.
Model Estimation
Because study variables could not be assumed to be normally distributed, full information
maximum likelihood estimation with robust standard errors was used. In addition, maximum
likelihood estimation is an optimal method for the treatment of missing data in a confirmatory
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factor analysis, as it is robust to missing completely at random and missing at random data
(Arbuckle, 1996).
Baseline Models
CESD-R
The baseline model demonstrated acceptable fit in the combined sample (χ2 [170] =
591.124, p < .001; RMSEA = .076 [90% CI: .07 - .083]; CFI = .853; TLI = .836; SRMR = .06),
thus providing sufficient evidence to proceed with multigroup factorial invariance testing.
DASS-21
The baseline model demonstrated good fit in the combined sample (χ2 [266] = 591.57, p
< .001; RMSEA = .054 [90% CI: .048 - .060]; CFI = .918; TLI = .910; SRMR = .043), thus
providing sufficient evidence to conduct multigroup factorial invariance testing.
ASRS
The baseline model demonstrated acceptable fit in the combined sample (χ2 [201] =
559.67, p < .001; RMSEA = .065 [90% CI: .059 - .072]; CFI = .868; TLI = .852; SRMR = .054),
thus providing sufficient evidence to conduct multigroup factorial invariance testing.
Multifactorial Invariance Analyses
CESD-R
Unstandardized parameter estimates for the test of configural invariance across the low
ASD traits and high ASD traits groups are presented in Figure 1a. Model fit indices for the test of
configural invariance are presented in Table 11.
Metric invariance. Unstandardized parameter estimates for the test of metric invariance
of the CESD-R across both the low ASD traits and high ASD traits groups are presented in
Figure 1b. Model fit indices for the test of metric invariance are presented in Table 11.
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DASS-21
Unstandardized parameter estimates for the test of configural invariance across the low
ASD traits and high ASD traits groups are presented in Figure 2a. Model fit indices for the test of
configural invariance are presented in Table 11.
Metric invariance. Unstandardized parameter estimates for the test of metric invariance
of the DASS-21 across the low ASD traits and high ASD traits groups are presented in Figure 2b.
Model fit indices for the test of metric invariance are presented in Table 11.
Scalar invariance. Unstandardized parameter estimates for the test of scalar invariance
of the DASS-21 across the low ASD traits and high ASD traits groups are presented in Figure 2c.
Model fit indices for the test of scalar invariance are presented in Table 11.
Strict invariance. Unstandardized parameter estimates for the test of strict invariance of
the DASS-21 across the low ASD traits and high ASD traits groups are presented in Figure 2d.
Model fit indices for the test of strict invariance of the DASS-21 are presented in Table 11.
ASRS
Unstandardized parameter estimates for the test of configural invariance across the low
ASD traits and high ASD traits groups are presented in Figure 3a. Model fit indices for the test of
configural invariance for the ASRS are presented in Table 11.
Metric invariance. Unstandardized parameter estimates for the test of metric invariance
of the ASRS across both the low ASD traits and high ASD traits groups are presented in Figure
3b. Model fit indices for the test of metric invariance are presented in Table 11.
Scalar invariance. Unstandardized parameter estimates for the test of scalar invariance
of the ASRS across the low ASD traits and high ASD traits groups are presented in Figure 3c.
Model fit indices for the test of scalar invariance for the ASRS are presented in Table 11.
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Strict invariance. Unstandardized parameter estimates for the test of strict invariance of
the ASRS across the low ASD traits and high ASD traits groups are presented in Figure 3d.
Model fit indices for the test of strict invariance of the ASRS are presented in Table 11.
Model Comparisons
Because all models were nested, all model comparisons were conducted via the
difference in each model’s chi-square value. The Satorra-Bentler scaled chi-square difference
test was used to examine differences in fit between models, given that maximum likelihood
estimation with robust standard errors was used in each model. Additionally, the sample sizeadjusted Bayesian Information Criterion (BIC) was used, with a 10-point difference taken as
evidence of a model difference in goodness of fit in favor of the model with the smaller BIC
(Raftery, 1993).
CESD-R
In general, both the configural and metric models possessed poor fit to the data, with all
model fit indices outside of the acceptable range (see Table 11). Consequently, multifactorial
invariance testing was discontinued and post-hoc exploratory factor analysis was conducted. In
order to determine if data were suitable for factor analysis, the Kaiser-Meyer-Olkin (KMO)
measure of sampling adequacy and Bartlett’s test of sphericity were assessed, with an overall
KMO of .8 or above considered excellent, and an overall KMO of less than .5 considered poor
(Tabachnick & Fidell, 2007). KMO for the CESD-R data was .943. Similarly, Bartlett’s test of
sphericity was significant, indicating that factor analysis on the CESD-R data would be suitable.
An exploratory factor analysis using maximum likelihood with robust standard errors
(MLR) with an oblique (geomin) rotation was used. A three-factor solution fit the data best, with
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three eigenvalues > 1 and RMSEA = 0.06 (90% CI: .054 - .069). Items within each of the three
identified factors are presented in Table 12.
DASS-21
Overall, the metric invariance model fit well, except for the standardized root mean
square residual (SRMR) index (see Table 11). The metric model did not exhibit a statistically
significant reduction in fit relative to the configural model, χ2(15) = 10.52, p = .785. This was
also supported when examining change in the sample size-adjusted BIC, as ΔBIC = 28.87 when
moving from the metric model to the configural model. The scalar invariance model also fit well
(see Table 11), and there was not a significant decrease in fit in relation to the metric invariance
model, χ2(18) = 18.09, p = .449. Similarly, when examining the scalar model in relation to the
metric model, ΔBIC = 32.34. Finally, the strict invariance model demonstrated acceptable fit
(see Table 11); however, the strict invariance model exhibited a significant decrease in fit
relative to the scalar model, χ2(21) = 157.32, p < .001, indicating that scalar invariance was
supported in the present sample.
ASRS
The metric invariance model possessed moderate to poor fit to the data (see Table 11).
The metric model did not demonstrate a statistically significant reduction in fit relative to the
configural model, χ2(14) = 10.77, p = .704. When examining change in sample-size adjusted
BIC, there was a difference of 28.95 when moving from the metric model to the configural
model. Model fit indices continued to be poorly fit to the data (see Table 11). When examining
the scalar model, there was a statistically significant reduction in fit relative to the metric model,
χ2(16) = 31.11, p =.013, indicating that scalar invariance of the measure was not supported in the
present sample. Finally, model fit indices were poor across all indicators for the test of strict
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factorial invariance (see Table 11). Consequently, the ASRS demonstrated metric invariance in
the current sample.
Discussion
Individuals with ASD present with high rates of anxiety and depression, with rates that
are greater than that seen in the general population (Croen et al., 2015; Joshi et al., 2013;
Wigham, Barton, Parr, & Rodgers, 2017). At the same time, the reliability and validity of many
traditional measures of these and other mental health conditions have not been tested in the ASD
population (Leyfer et al., 2006). Consequently, it is essential to assess whether common selfreport measures of anxiety and depression can adequately assess these constructs in individuals
with and without ASD. To this aim, the present study included factorial invariance analyses of
three self-report measures of psychiatric symptoms—the ASRS, the CESD-R, and the DASS21—among adults with low and high levels of ASD-related traits.
In comparison to the low ASD traits group, participants in the high ASD traits group
scored significantly higher on all study measures. Specifically, subscale scores and total scale
scores on the ASRS, the CESD-R, and the DASS-21 were significantly higher in the high ASD
traits group, indicating greater self-reported symptoms of depression, anxiety, stress, inattention,
and hyperactivity in those with a higher level of ASD-related traits.
Importantly, none of the self-report measures examined in the present study demonstrated
full factorial invariance, indicating that the measures are not consistent in their performance
across individuals with a high and low level of ASD-related traits.
Hypothesis 1
It was hypothesized that neither the CESD-R nor the DASS-21 would demonstrate metric
invariance across groups, given that traditional measures of anxiety and depression may not
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capture the presentation of these constructs in individuals with ASD, whether due to diagnostic
overshadowing, difficulty interpreting and reporting emotions, or another pathway (Cassidy et
al., 2018; Mazzone, Ruta, & Reale, 2012).
CESD-R
The original hypothesis that the CESD-R would not demonstrate metric invariance across
groups was supported in the current study. Indeed, the CESD-R did not demonstrate evidence of
acceptable model fit within the test of configural invariance, indicating that the same factor
model specification did not hold across both the low ASD traits and high ASD traits groups.
Instead, results of an exploratory factor analysis indicated that a three-factor solution fit the data
best.
In examining the items that loaded onto the three identified factors, several themes
appeared. One factor seemed to be concerned with negative affect (e.g., items included: “I could
not shake off the blues”; “I felt depressed”; “I felt sad”; “I did not like myself”; etc.). Another
factor involved physical symptoms associated with depression (e.g., items included: “My
appetite was poor”; “My sleep was restless”; “I felt like I was moving too slowly”; “I felt
fidgety”; etc.). Finally, the third factor comprised only two items, both of which could be related
to behavioral components of depression: “I wanted to hurt myself” and “I lost a lot of weight
without trying to.” The results of the exploratory factor analysis stand in contrast to previous
research from the initial validation of the measure which found that a one-factor solution
provided the best fit. Although results of the present study indicate that more than a single factor
provides the best fit to the data, it is possible that the overarching construct of depression is
common to all three identified factors and thus remains the most parsimonious factor model for
the measure as a whole.
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DASS-21
The original hypothesis that the DASS-21 would not demonstrate metric invariance
across groups was not supported in the present study. In contrast, there was evidence for scalar
invariance of the DASS-21, indicating equality in intercepts, factor loadings, and an identical
factor model specification across groups. Importantly, however, there was significant
degradation in model fit when examining strict invariance of the DASS-21, indicating that there
are not equal residual variances across the low ASD traits and high ASD traits groups.
Subsequently, the DASS-21 does not possess an identical item structure in those with a high and
low level of ASD-related traits; however, attaining scalar invariance justifies the comparisons of
group means on the latent constructs that the DASS-21 purports to measure (i.e., depression;
anxiety; stress). In this sense, group differences on items of the DASS-21 are not solely due to
differences on the common factors but are a result of some degree of measurement error. Given
that scalar invariance of the DASS-21 was supported in the current sample, one can have
confidence that the DASS-21 is able to measure symptoms of depression, anxiety, and stress
fairly consistently across individuals with a high and low level of ASD-related traits.
ASRS
The ASRS was also examined in the present study in order to obtain further information
about discriminant validity, as well as whether factorial invariance would be demonstrated
within measures that did not specifically measure internalizing symptoms. The ASRS
demonstrated metric invariance in the current sample, indicating equality in factor loadings in
addition to an identical factor model specification across groups. Importantly, however, there
was a significant decrease in model fit when examining scalar invariance of the ASRS,
indicating that there are not equal item intercepts across the low ASD traits and high ASD traits
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groups. Although the ASRS is measuring similar latent factors in both groups, it is not
performing equally across both groups at the level of individual items. Thus, the constructs being
measured by the ASRS (i.e., inattention; hyperactivity/impulsivity) have similar meanings to
individuals with varying levels of ASD-related traits, but the levels and relations among the
factors of the ASRS differ meaningfully in those with varying levels of ASD-related traits.
Because metric invariance was supported in the present sample, one can justify comparisons of
factor variances and covariances across those with a high and low level of ASD-related traits, but
one cannot assume that the ASRS functions equally in individuals with different levels of ASDrelated traits.
Hypothesis 2
Additionally, it was hypothesized that data from the CESD-R and the DASS-21 would
not possess the same factor model specifications in the high ASD traits group as were established
in general (Eaton, Smith, Ybarra, Muntaner, & Tien, 2004; Lovibond & Lovibond, 1995; Van
Dam & Earleywine, 2011) and clinical (Antony, Bieling, Cox, Enns, & Swinson, 1998; Brown,
Chorpita, Korotitsch, & Barlow, 1997) adult populations.
CESD-R
The hypothesis that the CESD-R would not possess the same factor model specifications
as established in general and clinical adult populations was supported in the present study. In
comparison to the standardized factor loadings from a confirmatory factor analysis conducted by
Van Dam and Earleywine (2011) of a community sample of 3650 adults, standardized factor
loadings of the CESD-R items for the high ASD traits group demonstrated a discrepancy of
greater than .30 for 9 out of 20 CESD-R items. For instance, items such as “I lost a lot of weight
without trying to” and “I felt fidgety” demonstrated respective factor loadings of .36 and .48 in
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the high ASD traits group of the current sample versus .61 and .76 in the work of Van Dam and
Earleywine (2011). In comparison, the same items possessed standardized factor loadings of .54
and .76 in the low ASD traits group of the current sample, in alignment with findings of Van
Dam and Earleywine (2011). Items that seemed most strongly associated with the construct of
depression in the community sample of Van Dam and Earleywine (2011) did not demonstrate
comparable factor loadings within the high ASD traits group of the current study. Specifically,
standardized factor loadings of items including “I felt sad”, “I could not get going”, “Nothing
made me happy”, “I felt like a bad person”, and “I lost interest in my usual activities” were all
within the range of .72-.83. In contrast, standardized factor loadings of the same items in the
community sample of Van Dam and Earleywine (2011) ranged from .91 to .98.
Consequently, within the population of adults with a high level of ASD-related traits,
several of the CESD-R items are not as highly correlated to the construct of depression as they
are in a general population sample; however, the causal explanation for this difference remains
unknown. For instance, it may be that there is a difference in the phenomenological experience
of depression for those with ASD as compared to neurotypical individuals. Future research is
needed to test this hypothesis explicitly.
DASS-21
The hypothesis that the DASS-21 would not possess the same factor model specifications
as established in general and clinical adult populations was not fully supported in the present
study.
In the original paper of Lovibond and Lovibond (1995), principal components analysis
was used to examine the psychometric properties of the DASS in a general sample of 717
university students. In comparison to the principal components analysis (PCA) conducted by
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Lovibond and Lovibond (1995), within the high ASD traits group, the DASS-21 demonstrated
higher factor loadings for every item except one (“I was intolerant of anything that kept me from
getting on with what I was doing”) in the present study. Specifically, for the Depression factor,
standardized factor loadings ranged from .61 to .85 in the present study’s test of configural
invariance, versus .45 to .80 in Lovibond and Lovibond’s (1995) PCA. Similarly, standardized
factor loadings for the Anxiety factor in the present study ranged from .63 to .82 versus .47 to .64
in the PCA of Lovibond and Lovibond (1995). Finally, standardized factor loadings for the
Stress factor ranged from .67 to .75 in the present study versus .41 to .73 in Lovibond and
Lovibond (1995). Overall, results indicated that items of the DASS-21 were more strongly
related to the overarching constructs of anxiety, depression, and stress within the group of
individuals with a high level of ASD-related traits than they were in the general population group
sampled in the original DASS study.
Brown, Chorpita, Korotitsch, and Barlow (1997) examined the psychometric properties
of the 42-item version of the DASS in a clinical sample of 241 patients presenting for assessment
and treatment at an anxiety disorders clinic. In the confirmatory factor analysis conducted by
Brown et al. (1997), factor loadings for the Depression factor ranged from .57 to .87; factor
loadings for the Anxiety factor ranged from .45 to .80; and factor loadings for the Stress factor
ranged from .60 to .79. Within the present study, factor loadings for all three factors in the high
ASD traits group were within the ranges identified by Brown et al. (1997) or slightly higher (i.e.,
Anxiety factor: .63-.82). Importantly, given that the 21-item version of the DASS was used in the
present study, these estimates are not fully comparable. In addition, because the DASS-21 has
been found to have a cleaner factor structure as compared to the full DASS (Antony et al., 1998),
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it is reasonable that the factor loadings in the present study would be somewhat higher, as the
short form possesses better psychometrics.
Finally, Antony, Bieling, Cox, Enns, and Swinson (1998) examined the psychometric
properties of the 42-item and 21-item versions of the DASS in a clinical sample of 258 adults
seeking outpatient treatment for depression or anxiety disorders. In their PCA of the DASS-21,
Antony et al. (1998) found factor loadings ranging from .55 to .91 for the Depression factor; .48
to .82 for the Anxiety factor; and .52 to .84 for the Stress factor. In comparison, the high ASD
traits group in the present study demonstrated similar factor loadings for the Depression factor
(.61-.85), and similar factor loadings for the Anxiety (.63-.82) and Stress (.67-.75) factors, albeit
that the range of scores was more restricted. Antony et al. (1998) emphasized that their findings
provided support for the DASS being consistent with the tripartite model of anxiety and
depression (Clark & Watson, 1991), in that scores on the Stress subscale were elevated across
anxious and depressed groups, whereas Depression subscale scores were only elevated in the
subgroup of individuals with depression. Importantly, however, further exploration of the DASS
in relation to the tripartite model within the population of individuals with ASD is needed in
order to determine whether the tripartite model would also be applicable to groups with ASD and
comorbid psychiatric diagnoses.
Hypothesis 3
Third, it was hypothesized that convergent validity would be demonstrated between the
CESD-R and the Depression scale of the DASS-21, as evidenced by significant correlation
coefficients. This hypothesis was supported in the present study. Specifically, within the overall
sample of 433 adults, the CESD-R and the DASS-21 Depression scale demonstrated a
significant, strong positive correlation (r = .86).
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This relationship held when looking at the two groups separately. For instance, within the
low ASD traits group, there was a significant correlation of .89 between the CESD-R total score
and the Depression scale of the DASS-21. Similarly, within the high ASD traits group, the
CESD-R total score and the Depression scale of the DASS-21 were significantly correlated at r =
.83. The similar correlations between the low ASD traits and high ASD traits groups support
convergent validity of the CESD-R with the DASS-21 Depression scale irrespective of group
membership, thus providing further confidence in the measurement of the construct of
depression in those with and without ASD.
Hypothesis 4
Finally, it was hypothesized that anxiety would be divergent from depression both within
and between self-report measures among the low ASD traits group, but not within the high ASD
traits group, given the potential for greater diagnostic overshadowing within ASD populations.
This hypothesis was not supported in the present study. Contrary to the stated hypothesis, there
were stronger correlations between depression and anxiety within the low ASD traits group as
compared to the high ASD traits group.
Specifically, when examining the relationship between the DASS-21 Depression and
Anxiety scales, there was a significant correlation of .78 in the low ASD traits group, and a
significant correlation of .68 in the high ASD traits group. Similarly, the DASS-21 Anxiety scale
and the CESD-R total score demonstrated a significant correlation of .80 in the low ASD traits
group versus a significant correlation of .66 in the high ASD traits group. These higher
correlations in the low ASD traits group as compared to the high ASD traits group run counter to
hypotheses, indicating that the constructs of depression and anxiety may not be highly divergent
even in individuals without ASD. Future research may wish to examine the DASS-21 and the
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CESD-R in relation to other self-report measures of depression and anxiety to determine the
extent to which these constructs are separable.
In addition, the relationship between the ASRS with both the CESD-R and the DASS-21
was also examined for further evidence of discriminant validity. The ASRS Inattention scale and
the DASS Anxiety scale demonstrated moderate positive correlations in both the low ASD traits
(r = .57) and high ASD traits (r = .43) groups. The relationship was similar for the ASRS
Inattention scale and self-report measures of depression. Specifically, the ASRS Inattention scale
demonstrated a significant correlation of .58 with the DASS Depression scale in both the low
ASD traits and high ASD traits groups. The ASRS Inattention scale was also moderately
correlated with the CESD-R, with significant correlations of .57 in both groups.
The ASRS Hyperactivity-Impulsivity scale also demonstrated moderate correlations with
anxiety and depression measures. For instance, it was correlated .62 with the DASS Anxiety
scale in both the low ASD traits and high ASD traits groups. The ASRS HyperactivityImpulsivity scale was moderately correlated with the CESD-R in the low ASD traits (r = .57) and
high ASD traits groups (r = .63), as well as the DASS Depression scale (r = .58 in both groups).
Importantly, symptoms of anxiety and depression may overlap with those of ADHD. In
particular, the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5;
American Psychiatric Association, 2013) specifies “restlessness or feeling keyed up or on edge”
as well as “difficulty concentrating or mind going blank” as symptoms associated with
generalized anxiety disorder. Similarly, “psychomotor agitation or retardation nearly every day”
and “diminished ability to think or concentrate, or indecisiveness, nearly every day” are listed as
symptoms of major depressive disorder. Therefore, some overlap between ADHD and
internalizing symptoms such as depression and anxiety is to be expected; however, the lack of
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any strong positive correlations (i.e., r ≥ .70) between the ASRS and the CESD-R or DASS-21
provides some evidence for the discriminability of ADHD symptoms from these constructs.
Limitations
There are several limitations inherent to the present study. First, individuals were sorted
into groups based upon their score on the AQ, rather than a clinically confirmed diagnosis of
ASD. Although the AQ has utility in distinguishing individuals with clinically significant levels
of ASD traits, with good discriminative validity and screening properties (Hurst et al., 2007;
Woodbury-Smith et al., 2005), it is not a diagnostic instrument. Consequently, the present results
are not directly generalizable to the population of individuals with and without confirmed autism
diagnoses. As a result, it is unknown whether these results would replicate in a sample of
individuals with confirmed autism diagnoses.
Secondly, the low and high ASD traits groups were created on the basis of a cut-off score
of 26 on the AQ, in fitting with previous research by Woodbury-Smith et al. (2005) which
demonstrated that this cut score correctly identified 83 percent of patients in a referred clinical
sample. Although the results of Woodbury-Smith et al. (2005) provide acceptable support for
sensitivity, their cut-off score of 26 is not perfectly sensitive in that it did not correctly identify
100 percent of patients with ASD in the sample. Importantly, the use of a cut-off score may be
flawed, in that there may not be a meaningful difference between those just above and just below
the cut score. In the present study, those with an AQ score equal or above 26 were classified as
the high ASD traits group; however, those with an AQ score of 25 may not be markedly different
from those with an AQ score of 26 or 27. Indeed, there may be meaningful variation in ASDrelated traits that is not captured with the use of a cut-off score.
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A critical limitation of the present study concerns the use of the online platform Amazon
Mechanical Turk. Although MTurk has several benefits, including the ability to collect a large
sample at low cost (Horton & Chilton, 2010) and respondent anonymity which may result in
greater comfort in disclosing psychiatric symptoms and mental health concerns (Shapiro,
Chandler, & Mueller, 2013), it also has several notable disadvantages. Specifically, previous
research regarding the use of MTurk to study clinical populations found a high proportion of
respondents to endorse items consistent with malingering (Shapiro, Chandler, & Mueller, 2013),
indicating that some participants may be exaggerating symptoms or faking distress. Further,
because MTurk workers are free to select the tasks that they wish to perform among a variety of
alternatives, there is an inherent selection bias that precludes collecting a fully representative
sample. Other evidence indicates that MTurk samples are not fully representative of the general
population. Indeed, according to the extant research literature, workers on MTurk tend to be
younger, overeducated, and underemployed as compared to the larger population of Internet
users and individuals in the general population (Paolacci, Chandler, & Ipeirotis, 2010). Of
particular relevance to the present study, previous research has indicated that MTurk workers are
more likely to possess traits associated with autism spectrum disorders (Mitchell & Locke,
2015), with AQ scores observed within the MTurk population one-third of a standard deviation
above those observed in a college student sample (Palmer, Paton, Enticott, & Hohwy, 2015). In
the same vein, McCredie and Morey (2018) conducted a study of 455 MTurk workers using the
Personality Assessment Inventory (PAI; Morey, 1991), and found that relative to a community
sample, MTurk workers scored higher on the social detachment and depression scales. Given
these results, it is likely that the present sample may not be fully representative of the general
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population and may also be more likely to endorse higher levels of ASD-related traits and/or
depression symptoms.
It is especially important to consider the extent to which MTurk is feasible as a tool for
behavioral research. Previously, Crump, McDonnell, and Gureckis (2013) replicated a variety of
experimental tasks using MTurk, including the Stroop (1935), Flanker (Ericksen & Ericksen,
1974), Simon (Craft & Simon, 1970), and attentional blink (Shapiro, Raymond, & Arnell, 1997)
tasks. Although Crump et al. (2013) found evidence for the validity of collecting experimental
behavioral data via MTurk, they also found that testing participants’ comprehension of
instructions was critical to robust data quality. In the present study, at least one attention check
was included in each measure (e.g., “Please select ‘1-2 days’ for this question”). Additionally,
participants were presented with an open-ended response for several of the demographic
information questions (e.g., “How do you currently describe your gender identity?”; “What is
your native language?”; “What is your age in years?”). Importantly, however, participants’ data
were not removed unless it was clear that participants did not comprehend the questions (e.g., a
participant answered “282019” when asked for their age in years) or failed all four attention
checks. Subsequently, the lack of explicit feedback regarding survey instructions may have
hindered some participants’ comprehension of survey items.
Finally, the present study is necessarily limited by its examination of a singular
population of interest: in this case, adults with and without a high level of ASD-related traits. As
such, other important constructs of interest were not examined. For instance, it is unknown to
what extent the study measures would demonstrate invariance with regard to age, ethnicity, or
other important factors. Future research would do well to investigate the invariance of these
measures with other group memberships of interest.
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Implications
There are several clinical and research implications inherent to the results of the present
study. Simply, and perhaps most notably, the finding of significantly higher scores on the CESDR, DASS-21, and ASRS within the high ASD traits group provides further support for the idea
that individuals with ASD experience higher levels of psychopathology as compared to
individuals without ASD (Brereton et al., 2006; Hudson et al., 2018; Roy et al., 2015), with
ADHD, anxiety, and depression being the most common comorbidities in adults with ASD
(Lever & Geurts, 2016). These findings highlight the need for further research into the
assessment and treatment of such conditions within this population, as well as any necessary
modifications to adapt existing measures and interventions to the unique needs of those with
ASD.
In particular, the finding of a lack of the most basic level of factorial invariance for the
CESD-R indicates that its factor model specification is not equivalent across adults with and
without a high level of ASD-related traits. Although the CESD-R was designed to be a valid
assessment of depression symptoms in epidemiological and community-based samples (Eaton et
al., 2004), it appears that it does not capture symptoms of depression in those with ASD in the
same way as compared to those who are neurotypical. Consequently, the lack of evidence for
factorial invariance suggests that the CESD-R may not be an ideal tool for assessment of
depression, at least as the construct is currently understood, for adults with a high level of ASDrelated traits.
The finding of scalar invariance across the two groups for the DASS-21 provides
evidence for cross-group equality in factor loadings and factor intercepts. In other words, scalar
invariance indicates that there are similar latent means and factor relationships on the DASS-21
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for those with high and low levels of ASD-related traits, such that any differences in the means
and covariances of DASS-21 items are due to differences in the latent parameters. These findings
provide support that the DASS-21 is operating similarly in individuals with and without a high
level of ASD-related traits. Thus, clinicians and researchers can have confidence that the DASS21 is measuring symptoms of depression, anxiety, and stress similarly and accurately across
those with and without a high level of ASD-related traits.
Multigroup factorial invariance analyses of the ASRS provided support for metric
invariance of the measure, indicating that the same latent constructs are being measured across
individuals with high and low levels of ASD-related traits. At the same time, the lack of evidence
for scalar invariance across groups suggests that there are different factor relationships, latent
means, and observed error variances for those with high and low levels of ASD-related traits. In
this case, when using the ASRS in those with a high level of ASD traits, one can assume to
adequately measure the latent constructs of inattention and hyperactivity-impulsivity.
Conversely, however, one cannot assume that the levels and relationships among the constructs
of inattention and hyperactivity-impulsivity will be the same in those with a high level of ASD
traits. In this sense, clinicians should proceed with caution when using the ASRS to assess
symptoms of ADHD in those with ASD.
Finally, the finding of stronger correlations between measures of depression and anxiety
within the low ASD traits group as compared to the high ASD traits group provides evidence that
these constructs may be relatively more distinct in those with a high level of ASD traits. The
reason for this finding is unknown, but it is possible that those with ASD experience depression
and anxiety in a way that is qualitatively different from neurotypical individuals and is not
adequately captured by items on either the CESD-R or the DASS-21. Future research may wish
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to explore additional behavioral and cognitive signs of anxiety and depression that may be
unique to those with ASD.
Conclusions
Individuals with ASD experience internalizing symptoms, including depression and
anxiety, at a higher rate than do individuals without ASD (Buck et al., 2014; Cassidy et al., 2014;
Joshi et al., 2013). Although the extant literature indicates that depression and anxiety are highly
prevalent in the ASD population, research on the psychometric properties of commonly used
self-report measures of depression and anxiety within this population is limited. Importantly,
because most measures of anxiety and depression have not been normed with individuals with
ASD, one cannot assume that these measures reliably or validly assess these constructs in people
with ASD.
The current study sought to examine the factor structures of the DASS-21 and the CESDR in individuals with a high and low level of ASD-related traits as measured by the AQ. It also
examined convergent and discriminant validity of these measures. This was one of the first
studies to examine factorial invariance of the DASS-21 and the CESD-R in individuals with and
without a high level of ASD traits. Results suggest that the DASS-21 and the CESD-R are not
fully invariant across those with and without a high level of ASD traits, such that scores on these
measures include some degree of measurement bias. As a result, the DASS-21 and the CESD-R
should be interpreted with caution when assessing symptoms of depression and anxiety in those
with ASD. The present analyses provide support for the idea that an alternative assessment is
needed in order to adequately measure the constructs of anxiety and depression in individuals
with ASD.
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Table 1
Demographic Characteristics of Low and High ASD Trait Groups
Variable

Low ASD Traits
Sample Mean (SD)
36.08 (11.67)

High ASD Traits
Sample Mean (SD)
34.81 (10.12)

Between-group
difference p value
.301a

CESD-R Total

11.36 (14.11)

20.27 (16.79)

< .001a

AQ Total

17.39 (5.82)

29.18 (3.56)

< .001a

DASS_Depression

3.82 (5.08)

6.71 (5.70)

< .001a

DASS_Anxiety

2.60 (3.95)

5.19 (5.05)

< .001a

DASS_Stress

3.81 (4.6)

7.13 (5.1)

< .001a

ASRS_Inattention

10.78 (7.4)

14.00 (7.3)

< .001a

ASRS_Hyperactivity

8.93 (6.36)

12.32 (6.78)

< .001a

Low ASD
Traits Sample
(n = 203)

High ASD
Traits Sample
(n = 231)

Between-group
difference p
value
0.08b

128 (63.05%)

130 (56.28%)

Age

Note. aMann-Whitney U test.
Variable

Gender
Male

0.06b

Native Language
English
Racial/Ethnic Background
American
Indian/Alaska Native

200 (98.5%)

216 (93.5%)
0.14b

0 (0%)

1 (.04%)

Asian

14 (6.9%)

12 (5.2%)

Black/African
American

14 (6.89%)

13 (5.62%)

Hispanic, Latino, or
Spanish Origin

12 (5.91%)

16 (6.92%)

0 (0%)

1 (.04%)

Middle Eastern or
North African
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Native Hawaiian or
Other Pacific Islander

0 (0%)

1 (.04%)

153 (75.4%)

160 (69.26%)

Multiracial or
multiethnic

9 (4.43%)

16 (6.92%)

I prefer not to answer

1 (.04%)

2 (.08%)

White

Note. bχ2 test.
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Table 2
Bivariate Correlations among ASRS Items, Low ASD Traits Group
Variable

1.

2.

3.

4.

5.

6.

7.

8.

9.

10. 11. 12. 13. 14. 15. 16. 17. 18.

1.

1.0

2.

.65 1.0

3.

.63 .62 1.0

4.

.62 .61 .57 1.0

5.

.51 .57 .55 .56 1.0

6.

.41 .54 .48 .55 .61 1.0

7.

.49 .57 .50 .51 .55 .61 1.0

8.

.53 .61 .59 .51 .53 .46 .54 1.0

9.

.55 .53 .48 .60 .50 .60 .55 .50 1.0

10.

.35 .42 .43 .46 .40 .49 .49 .43 .49 1.0

11.

.37 .33 .30 .33 .36 .28 .41 .28 .32 .43 1.0

12.

.38 .44 .49 .33 .53 .37 .49 .48 .33 .36 .32 1.0

13.

.46 .48 .41 .47 .45 .53 .49 .52 .47 .71 .52 .40 1.0
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14.

.45 .50 .42 .42 .45 .45 .43 .39 .51 .38 .41 .49 .51 1.0

15.

.39 .43 .34 .42 .54 .38 .52 .40 .42 .35 .43 .46 .35 .39 1.0

16.

.33 .33 .30 .36 .38 .33 .50 .31 .37 .38 .38 .30 .39 .24 .56 1.0

17.

.46 .52 .55 .40 .50 .34 .55 .49 .42 .42 .34 .56 .43 .37 .58 .49 1.0

18.

.27 .40 .30 .29 .54 .34 .51 .42 .40 .42 .26 .49 .37 .38 .53 .57 .60 1.0

Note. N = 202. All correlations were significant at p < .0001.
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Table 3
Bivariate Correlations among ASRS Items, High ASD Traits Group
2.

3.

4.

5.

6.

7.

8.

9.

10.

11.

12.

13.

14.

15.

16.

17.

Variable

1.

1.

1.0

2.

.54***

1.0

3.

.43***

.56***

1.0

4.

.38***

.46***

.37***

1.0

5.

.38***

.46***

.36***

.46***

1.0

6.

.50***

.44***

.36***

.51***

.47***

1.0

7.

.35***

.36***

.37***

.48***

.49***

.51***

1.0

8.

.34***

.48***

.40***

.35***

.43***

.38***

.32***

1.0

9.

.36***

.41***

.40***

.41***

.45***

.48***

.44***

.37***

1.0

10.

.37***

.35***

.37***

.36***

.31***

.47***

.36***

.38***

.44***

1.0

11.

.22**

.21**

.24***

.23***

.32***

.30***

.41***

.25***

.35***

.42***

1.0

12.

.39***

.52***

.35***

.19**

.36***

.30***

.31***

.46***

.32***

.34***

.39***

1.0

13.

.25***

.31***

.28***

.24***

.36***

.41***

.37***

.31***

.41***

.59***

.40***

.30***

1.0

14.

.35***

.35***

.31***

.23**

.25***

.42***

.35***

.28***

.42***

.42***

.33***

.32***

.41***

1.0

15.

.33***

.24***

.29***

.13

.29***

.24***

.18**

.36***

.34***

.15*

.26***

.44***

.20**

.23**

1.0

16.

.25***

.27***

.18**

.18**

.45***

.21**

.13

.26***

.27***

.09

.23**

.37***

.19**

.13

.45***

1.0

17.

.33***

.35***

.32***

.17*

.48***

.28***

.16**

.30***

.33***

.19**

.24***

.44***

.27***

.26***

.50***

.55***

1.0

18.

.33***

.37***

.31***

.18**

.40***

.34***

.27***

.29***

.37***

.17*

.27***

.41***

.17**

.31***

.40***

.44***

.59***

Note. N = 221. *p < .05. **p < .01. ***p < .001.
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18.

1.0

Table 4
Bivariate Correlations among DASS-21 Items, Low ASD Traits Group
Variable

1.

2.

3.

4.

5.

6.

7.

8.

9.

10. 11. 12. 13. 14. 15. 16. 17. 18. 19. 20. 21.

1.

1.0

2.

.59 1.0

3.

.75 .63 1.0

4.

.73 .59 .72 1.0

5.

.75 .65 .75 .70 1.0

6.

.72 .61 .72 .75 .68 1.0

7.

.74 .57 .76 .67 .70 .77 1.0

8.

.48 .47 .39 .34 .51 .35 .37 1.0

9.

.48 .44 .45 .44 .41 .46 .42 .45 1.0

10.

.62 .51 .57 .60 .52 .53 .53 .42 .53 1.0

11.

.60 .56 .55 .60 .61 .63 .58 .46 .52 .50 1.0

12.

.54 .49 .50 .53 .59 .55 .51 .52 .57 .59 .58 1.0

13.

.58 .55 .55 .60 .61 .54 .55 .52 .65 .61 .60 .76 1.0
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14.

.64 .57 .68 .62 .66 .65 .65 .49 .62 .66 .65 .66 .66 1.0

15.

.47 .54 .51 .44 .55 .49 .44 .40 .40 .47 .50 .54 .49 .51 1.0

16.

.65 .57 .69 .59 .65 .62 .62 .47 .45 .53 .48 .54 .56 .58 .54 1.0

17.

.64 .57 .60 .57 .61 .62 .57 .40 .57 .57 .63 .57 .63 .62 .56 .66 1.0

18.

.59 .62 .60 .64 .60 .62 .57 .45 .53 .55 .64 .62 .65 .58 .56 .67 .63 1.0

19.

.54 .54 .57 .59 .65 .61 .55 .43 .37 .48 .62 .61 .53 .58 .66 .54 .57 .60 1.0

20.

.60 .52 .64 .58 .64 .57 .61 .44 .39 .55 .53 .58 .57 .60 .50 .65 .54 .67 .55 1.0

21.

.57 .53 .53 .61 .59 .64 .47 .46 .52 .55 .64 .61 .61 .63 .53 .61 .61 .74 .59 .64 1.0

Note. N = 202. All correlations were significant at p < .001.
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Table 5
Bivariate Correlations among DASS-21 Items, High ASD Traits Group
Variable

1.

2.

3.

4.

5.

6.

7.

8.

9.

10. 11. 12. 13. 14. 15. 16. 17. 18. 19. 20. 21.

1.

1.0

2.

.55 1.0

3.

.66 .49 1.0

4.

.65 .47 .72 1.0

5.

.63 .51 .55 .61 1.0

6.

.57 .48 .73 .67 .58 1.0

7.

.61 .41 .71 .66 .61 .71 1.0

8.

.38 .40 .40 .35 .45 .41 .37 1.0

9.

.46 .36 .42 .43 .41 .41 .41 .54 1.0

10.

.46 .35 .36 .37 .43 .40 .43 .49 .59 1.0

11.

.39 .47 .45 .50 .42 .47 .41 .45 .45 .44 1.0

12.

.51 .40 .51 .55 .48 .45 .49 .44 .57 .62 .61 1.0

13.

.45 .44 .43 .48 .46 .45 .40 .46 .59 .62 .51 .62 1.0
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14.

.47 .40 .43 .42 .49 .45 .40 .49 .52 .51 .56 .64 .59 1.0

15.

.49 .48 .48 .54 .45 .47 .46 .42 .38 .41 .50 .49 .46 .40 1.0

16.

.57 .50 .49 .45 .58 .48 .50 .42 .45 .45 .51 .48 .34 .54 .47 1.0

17.

.41 .43 .47 .49 .43 .46 .41 .46 .45 .50 .61 .63 .58 .49 .46 .44 1.0

18.

.45 .48 .50 .50 .49 .46 .45 .33 .39 .38 .51 .51 .48 .47 .52 .56 .48 1.0

19.

.47 .50 .47 .51 .53 .44 .48 .45 .39 .42 .51 .58 .43 .46 .67 .49 .56 .53 1.0

20.

.45 .41 .46 .49 .53 .49 .51 .35 .31 .31 .44 .40 .40 .38 .41 .52 .35 .55 .41 1.0

21.

.55 .51 .54 .54 .54 .56 .52 .34 .37 .38 .50 .42 .46 .46 .49 .57 .42 .63 .44 .61 1.0

Note. N = 220. All correlations were significant at p < .001.
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Table 6
Bivariate Correlations among CESD-R Items, Low ASD Traits Group
Variable

1.

2.

3.

4.

5.

6.

7.

8.

9.

10. 11. 12. 13. 14. 15. 16. 17. 18. 19. 20.

1.

1.0

2.

.82

1.0

3.

.79

.88 1.0

4.

.73

.73 .69 1.0

5.

.66

.69 .70 .73 1.0

6.

.39

.38 .45 .36 .44 1.0

7.

.39

.29 .41 .46 .42 .57 1.0

8.

.56

.51 .49 .54 .50 .33 .29 1.0

9.

.41

.43 .46 .42 .52 .56 .48 .26 1.0

10.

.49

.50 .44 .44 .48 .30 .25 .77 .33 1.0

11.

.62

.67 .69 .71 .67 .45 .48 .39 .52 .39 1.0

12.

.73

.75 .77 .75 .68 .39 .45 .40 .42 .37 .71 1.0

13.

.63

.67 .61 .61 .65 .32 .25 .60 .46 .59 .58 .48 1.0
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14.

.61

.61 .65 .61 .62 .39 .38 .66 .36 .57 .54 .62 .66 1.0

15.

.53

.46 .49 .50 .53 .48 .51 .40 .46 .23 .52 .48 .40 .46 1.0

16.

.60

.61 .66 .66 .64 .42 .46 .50 .36 .41 .61 .67 .50 .57 .57 1.0

17.

.68

.65 .67 .63 .71 .40 .47 .54 .42 .51 .64 .63 .68 .63 .52 .62 1.0

18.

.59

.60 .64 .66 .74 .49 .49 .51 .53 .49 .70 .68 .70 .63 .55 .63 .76 1.0

19.

.50

.48 .56 .57 .43 .27 .46 .35 .24 .18 .48 .51 .23 .36 .40 .57 .33 .32 1.0

20.

.36

.51 .55 .46 .52 .48 .47 .27 .41 .28 .62 .50 .37 .38 .38 .54 .53 .47 .42 1.0

Note. N = 203. All correlations were significant at p < .001.
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Table 7
Bivariate Correlations among CESD-R Items, High ASD Traits Group
Variable

1.

2.

3.

4.

5.

6.

7.

8.

9.

10.

1.

1.0

2.

.75***

1.0

3.

.76***

.80***

1.0

4.

.70***

.68***

.69***

1.0

5.

.69***

.62***

.66***

.67***

1.0

6.

.43***

.40***

.45***

.37***

.52***

1.0

7.

.26***

.20**

.19*

.27***

.27***

.47***

1.0

8.

.49***

.48***

.55***

.51***

.55***

.45***

.2**

1.0

9.

.43***

.41***

.41***

.37***

.48***

.46***

.45***

.30***

1.0

10.

.44***

.52***

.50***

.47***

.47***

.38***

.13*

.73***

.29***

1.0

11.

.62***

.64***

.65***

.67***

.63***

.37***

.35***

.46***

.38***

.44***

1.0

12.

.69***

.71***

.67***

.66***

.69***

.44***

.30***

.49**

.43***

.49***

.71***

1.0

13.

.58***

.56***

.53***

.56***

.62***

.43***

.21**

.53***

.46***

.43***

.49***

.56***

1.0

14.

.38***

.49***

.49***

.48***

.48***

.34***

.05

.51***

.35***

.50***

.35***

.50***

.60***

1.0

15.

.47***

.50***

.46***

.47***

.53***

.39***

.39***

.41***

.51***

.42***

.50***

.59***

.49***

.45***

1.0

16.

.26***

.35***

.37***

.31***

.36***

.31***

.23**

.46***

.23**

.48***

.44***

.37***

.34***

.31***

.38***

1.0

17.

.55***

.59***

.56***

.45***

.54***

.41***

.15*

.47***

.40***

.47***

.48***

.50***

.59***

.44***

.42***

.36***

1.0

18.

.58***

.63***

.61***

.56***

.64***

.41***

.26***

.55***

.43***

.50***

.61***

.66***

.67***

.49***

.62***

.50***

.72***

1.0

19.

.46***

.50***

.45***

.45***

.47***

.27***

.53***

.29***

.53***

.34***

.56***

.53***

.34***

.24**

.46***

.24**

.35***

.47***

1.0

20.

.34***

.38***

.37***

.44***

.37***

.30***

.59***

.17**

.42***

.31***

.48***

.49***

.28***

.19**

.47***

.27***

.22**

.37***

.72***

Note. N = 221. *p < .05. **p < .01. ***p < .001.
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11.

12.

13.

14.

15.

16.

17.

18.

19.

20.

1.0

Table 8
Skewness and Kurtosis Statistics for Items
Variable
AQ1
AQ2
AQ3
AQ4
AQ5
AQ6
AQ7
AQ8
AQ9
AQ10
AQ11
AQ12
AQ13
AQ14
AQ15
AQ16
AQ17
AQ18
AQ19
AQ20
AQ21
AQ22
AQ23
AQ24
AQ25
AQ26
AQ27
AQ28
AQ29
AQ30
AQ31
AQ32
AQ33
AQ34
AQ35
AQ36
AQ37
AQ38
AQ39
AQ40
AQ41
AQ42

Skewness
-.27
-.45
1.46
-.55
-.64
-.27
.82
1.46
.46
.41
-.34
-1.12
-.52
.13
-.12
-.44
.41
.74
-.11
1.01
.94
-.40
-.71
-.07
-.61
-.31
.96
.17
.24
-.51
1.33
.41
.33
-.005
.77
.89
.61
-.29
.58
.82
-.04
.15
65

Kurtosis
-1.94
-1.81
.14
-1.70
-1.60
-1.94
-1.34
.14
-1.79
-1.84
-1.89
-.75
-1.74
-1.99
-.75
-1.81
-1.83
-1.47
-1.99
-.98
-1.13
-1.85
-1.50
-2.00
-1.64
-1.92
-1.08
-1.98
-1.95
-1.75
-.24
-1.84
-1.90
-2.00
-1.42
-1.20
-1.64
-1.93
-1.67
-1.34
-2.00
-1.99

AQ43
AQ44
AQ45
AQ46
AQ47
AQ48
AQ49
AQ50
DASS-1
DASS-2
DASS-3
DASS-4
DASS-5
DASS-6
DASS-7
DASS-8
DASS-9
DASS-10
DASS-11
DASS-12
DASS-13
DASS-14
DASS-15
DASS-16
DASS-17
DASS-18
DASS-19
DASS-20
DASS-21
ASRS-1
ASRS-2
ASRS-3
ASRS-4
ASRS-5
ASRS-6
ASRS-7
ASRS-8
ASRS-9
ASRS-10
ASRS-11
ASRS-12
ASRS-13
ASRS-14
ASRS-15
ASRS-16
ASRS-17

-1.46
-.04
.63
-.91
-.03
.58
.30
.52
.82
1.15
1.00
1.54
.83
.89
1.69
.88
1.07
.87
.74
.80
.80
.97
1.29
.95
1.04
.83
1.19
1.36
1.26
.47
.52
.63
.30
.39
.54
.57
.19
.63
.35
.30
1.09
.56
.35
.81
.76
.77
66

.14
-2.00
-1.62
-1.18
-2.00
-1.67
-1.92
-1.74
-.20
.42
.009
1.58
-.25
-.23
1.97
-.38
.029
-.49
-.45
-.44
-.53
.03
.53
-.23
-.15
-.27
.30
.83
.46
-.27
-.37
-.35
-.69
-.87
-.48
-.14
-.65
-.34
-.57
-.59
.45
-.27
-.56
.03
-.17
-.16

ASRS-18
CESD-R-1
CESD-R-2
CESD-R-3
CESD-R-4.
CESD-R-5
CESD-R-6
CESD-R-7
CESD-R-8
CESD-R-9
CESD-R-10
CESD-R-11
CESD-R-12
CESD-R-13
CESD-R-14
CESD-R-15
CESD-R-16
CESD-R-17
CESD-R-18
CESD-R-19
CESD-R-20

.68
1.63
1.23
1.08
1.11
.76
1.12
1.15
1.35
1.43
1.26
1.50
1.48
1.33
2.26
2.75
.98
1.1
2.44
1.02
.97
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.13
2.20
.54
.43
.16
-.52
.24
.48
.96
1.08
.76
1.70
1.24
.79
4.64
7.81
-.14
-.03
5.40
-.10
-.03

Table 9
Bivariate Correlations between Subscale Scores on Study Measures
Low ASD Traits (n = 203)
2.
3.
4.
5.

Measure
1. CESD-R

1.
1.0

2. DASS Depression
3. DASSAnxiety
4. DASS-Stress

.89

1.0

.80

.78

1.0

.82

.84

.83

6.

1.0

5. ASRS .57
.58
.57
.62
Inattention
6. ASRS –
.57
.58
.62
.67
Hyperactivity
Impulsivity
Note. All correlations were significant at p < .001.

1.0
.77

1.0

68

1.
1.0

High ASD Traits (n =220)
2.
3.
4.
5.

.83

1.0

.66

.68

1.0

.77

.80

.77

1.0

.57

.58

.43

.56

1.0

.63

.58

.62

.67

.75

6.

1.0

Table 10
Internal Consistency of Study Measures
Measure

Total Sample

Low ASD Traits

High ASD Traits

(n = 422 - 424)

(n = 202- 203)

(n = 220 -221)

CESD-R

.953

.955

.944

DASS-21

.962

.966

.95

DASS –
Depression

.931

.94

.913

DASS –
Anxiety

.905

.904

.891

DASS –
Stress

.906

.915

.875

ASRS –
Total

.927

.936

.903

ASRS –
Inattention

.90

.917

.869

.87

.813

ASRS –
.853
Hyperactivity
Impulsivity
Note. All estimates are Cronbach’s α.
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Table 11
Goodness of Fit Indices for Alternative Confirmatory Factor Analysis Models
Measure

Model

Χ2

df

p

RMSEA

CFI

SRMR

TLI

AIC

BIC

.808

.077

.785

20145.31 20252.23

.805

.086

.793

20150.28 20240.55

.954

.229

.949

16959.46 17073.65

.955

.228

.951

16943.67 17044.78

.954

.229

.953

16927.02 17012.44

.901

.230

.903

17246.68 17313.79

.849

.108

.827

19752.64 19848.79

.848

.110

.84

19735.93 19819.84

.842

.110

.84

19735.49 19805.42

.816

.116

.822

19808.46 19862.65

[90% CI]

CESD-R

DASS-21

ASRS

Configural

949.14

338

< .001

Metric

978.45

357

< .001

Configural

527.06

373

< .001

Metric

539.86

388

< .001

Scalar

560.47

406

< .001

Strict

761.68

427

< .001

Configural

672.44

268

< .001

Metric

687.47

282

< .001

Scalar

720.08

298

< .001

Strict

807.66

316

< .001

.092
[.085, .099]
.091
[.084, .097]
.04
[.035, .053]
.043
[.034, .051]
.042
[.034, .051]
.061
[.054, .068]
.084
[.077, .092]
.082
[.075, .09]
.082
[.074, .089]
.086
[.078, .093]
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Note. RMSEA = root mean square error of approximation; CFI = comparative fit index; SRMR = standardized root mean square
residual; TLI = Tucker Lewis Index; AIC = Akaike Information Criterion; BIC = sample size-adjusted Bayesian Information
Criterion.
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Table 12
Results of Exploratory Factor Analysis of the CESD-R
Item

Factor 1:
Negative
Affect

Factor 2:
Physical
Symptoms

Factor 3:
Behavior
Changes

Communality

My appetite was poor.

-.021

.505

.323

.359

I could not shake off
the blues.

.865

.050

-.150

.773

I had trouble keeping
my mind on what I
was doing.

.130

.673

-.003

.469

I felt depressed.

.997

-.021

-.236

1.04

My sleep was restless.

-.227

.950

-.004

.954

I felt sad.

.928

.022

-.183

.895

I could not get going.

.031

.784

-.034

.616

Nothing made me
happy.

.730

.121

-.025

.548

I felt like a bad person.

.597

.175

.143

.407

72

I lost interest in my
usual activities.

.362

.474

.066

.360

I slept much more than
usual.

.045

.416

.375

.315

I felt like I was
moving too slowly.

.031

.542

.346

.414

I felt fidgety.

.026

.572

.156

.352

I wished I were dead.

.674

-.179

.353

.610

I wanted to hurt
myself.

.377

.008

.531

.424

I was tired all the time.

-.024

.775

-.059

.604

I did not like myself.

.743

.114

.026

.565

I lost a lot of weight
without trying to.

-.016

.220

.711

.554

I had a lot of trouble
getting to sleep.

-.187

.862

-.002

.778

I could not focus on
the important things.

.010

.789

.156

.646

10.681

1.606

1.140

Eigenvalues

73

Correlations among factors

1
2
3

1
.825
.383

74

2

3

.193

-

Figure 1a. Unstandardized parameter estimates for configural invariance of the CESD-R. Estimates for the high ASD traits cohort are
presented in boldface following estimates for the low ASD traits cohort.
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Figure 1b. Unstandardized parameter estimates for metric invariance of the CESD-R. Factor loadings were constrained to be equal
across groups. Estimates for the high ASD traits cohort are presented in boldface following estimates for the low ASD traits cohort.
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Figure 2a. Unstandardized parameter estimates for configural invariance of the DASS-21. Estimates for the high ASD traits cohort are
presented in boldface following estimates for the low ASD traits cohort.
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Figure 2b. Unstandardized parameter estimates for metric invariance of the DASS-21. Factor loadings were constrained to be equal
across groups. Estimates for the high ASD traits cohort are presented in boldface following estimates for the low ASD traits cohort.
78

Figure 2c. Unstandardized parameter estimates for scalar invariance of the DASS-21. Factor loadings and intercepts were constrained
to be equal across groups. Estimates for the high ASD traits cohort are presented in boldface following estimates for the low ASD
traits cohort.
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Figure 2d. Unstandardized parameter estimates for strict invariance of the DASS-21. Factor loadings, intercepts, and residual
variances were constrained to be equal across groups. Estimates for the high ASD traits cohort are presented in boldface following
estimates for the low ASD traits cohort.
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Figure 3a. Unstandardized parameter estimates for configural invariance of the ASRS. Estimates for the high ASD traits cohort are
presented in boldface following estimates for the low ASD traits cohort.
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Figure 3b. Unstandardized parameter estimates for metric invariance of the ASRS. Factor loadings were constrained to be equal
across groups. Estimates for the high ASD traits cohort are presented in boldface following estimates for the low ASD traits cohort.

82

Figure 3c. Unstandardized parameter estimates for scalar invariance of the ASRS. Factor loadings and intercepts were constrained to
be equal across groups. Estimates for the high ASD traits cohort are presented in boldface following estimates for the low ASD traits
cohort.

83

Figure 3d. Unstandardized parameter estimates for strict invariance of the ASRS. Factor loadings, intercepts, and residual variances
were constrained to be equal across groups. Estimates for the high ASD traits cohort are presented in boldface following estimates for
the low ASD traits cohort.
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